<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE Publisher
  PUBLIC "-//Springer-Verlag//DTD A++ V2.4//EN" "http://devel.springer.de/A++/V2.4/DTD/A++V2.4.dtd">
<Publisher>
  <PublisherInfo>
    <PublisherName>Humana Press</PublisherName>
    <PublisherLocation>Totowa, NJ</PublisherLocation>
    <PublisherImprintName>Humana Press</PublisherImprintName>
  </PublisherInfo>
  <Series>
    <SeriesInfo SeriesType="Series" TocLevels="0">
      <SeriesID>7651</SeriesID>
      <SeriesPrintISSN>1064-3745</SeriesPrintISSN>
      <SeriesElectronicISSN>1940-6029</SeriesElectronicISSN>
      <SeriesTitle Language="En">Methods in Molecular Biology™</SeriesTitle>
      <SeriesSubTitle Language="En">Methods and Protocols</SeriesSubTitle>
      <SeriesAbbreviatedTitle>Methods Molecular Biology</SeriesAbbreviatedTitle>
    </SeriesInfo>
    <Book Language="En">
      <BookInfo BookProductType="Contributed volume" ContainsESM="No" Language="En" MediaType="eBook" NumberingStyle="ChapterContentSeparately" OutputMedium="All" TocLevels="0">
        <BookID>978-1-60327-931-4</BookID>
        <BookTitle>Neural Cell Transplantation</BookTitle>
        <BookSubTitle>Methods and Protocols</BookSubTitle>
        <BookVolumeNumber>549</BookVolumeNumber>
        <BookSequenceNumber>549</BookSequenceNumber>
        <BookDOI>10.1007/978-1-60327-931-4</BookDOI>
        <BookTitleID>160368</BookTitleID>
        <BookPrintISBN>978-1-60327-930-7</BookPrintISBN>
        <BookElectronicISBN>978-1-60327-931-4</BookElectronicISBN>
        <BookEdition>1</BookEdition>
        <BookChapterCount>16</BookChapterCount>
        <BookCopyright>
          <CopyrightHolderName>Humana Press</CopyrightHolderName>
          <CopyrightYear>2009</CopyrightYear>
        </BookCopyright>
        <BookSubjectGroup>
          <BookSubject Code="L" Type="Primary">Life Sciences</BookSubject>
          <BookSubject Code="L16008" Priority="1" Type="Secondary">Cell Biology</BookSubject>
          <BookSubject Code="L16010" Priority="2" Type="Secondary">Stem Cells</BookSubject>
          <SubjectCollection Code="SUCO11642">Biomedical and Life Sciences</SubjectCollection>
        </BookSubjectGroup>
        <BookContext>
          <SeriesID>7651</SeriesID>
        </BookContext>
      </BookInfo>
      <BookHeader>
        <EditorGroup>
          <Editor>
            <EditorName DisplayOrder="Western">
              <GivenName>David</GivenName>
              <FamilyName>Gordon</FamilyName>
            </EditorName>
            <Contact>
              <Email>d.gordon@bristol.ac.uk</Email>
            </Contact>
          </Editor>
          <Editor>
            <EditorName DisplayOrder="Western">
              <GivenName>Neil J.</GivenName>
              <FamilyName>Scolding</FamilyName>
            </EditorName>
            <Contact>
              <Phone>+440177918-6632</Phone>
              <Email>n.j.scolding@tesco.net</Email>
            </Contact>
          </Editor>
          <Affiliation ID="AffID1">
            <OrgDivision>Frenchay Hospital</OrgDivision>
            <OrgName>University of Bristol</OrgName>
            <OrgAddress>
              <City>Bristol</City>
              <Postcode>BS16 1LE</Postcode>
              <Country>United Kingdom</Country>
            </OrgAddress>
          </Affiliation>
          <Affiliation ID="AffID2">
            <OrgDivision>Frenchay Hospital</OrgDivision>
            <OrgName>University of Bristol</OrgName>
            <OrgAddress>
              <City>Bristol</City>
              <Postcode>BS16 1LE</Postcode>
              <Country>United Kingdom</Country>
            </OrgAddress>
          </Affiliation>
        </EditorGroup>
      </BookHeader>
      <Part ID="Part2">
        <PartInfo OutputMedium="All" TocLevels="0">
          <PartID>2</PartID>
          <PartSequenceNumber>2</PartSequenceNumber>
          <PartTitle> Practical/Methodological Chapters</PartTitle>
          <PartChapterCount>13</PartChapterCount>
          <PartContext>
            <SeriesID>7651</SeriesID>
            <BookID>978-1-60327-931-4</BookID>
            <BookTitle>Neural Cell Transplantation</BookTitle>
          </PartContext>
        </PartInfo>
        <Chapter ID="Chap9" Language="En">
          <ChapterInfo ChapterType="OriginalPaper" ContainsESM="No" Language="En" NumberingStyle="ChapterContentSeparately" OutputMedium="All" TocLevels="0">
            <ChapterID>9</ChapterID>
            <ChapterNumber>9</ChapterNumber>
            <ChapterDOI>10.1007/978-1-60327-931-4_9</ChapterDOI>
            <ChapterSequenceNumber>9</ChapterSequenceNumber>
            <ChapterTitle Language="En">Umbilical Cord Blood Cells</ChapterTitle>
            <ChapterFirstPage>119</ChapterFirstPage>
            <ChapterLastPage>136</ChapterLastPage>
            <ChapterCopyright>
              <CopyrightHolderName>Humana Press, a part of Springer Science+Business Media, LLC</CopyrightHolderName>
              <CopyrightYear>2009</CopyrightYear>
            </ChapterCopyright>
            <ChapterHistory>
              <RegistrationDate>
                <Year>2009</Year>
                <Month>1</Month>
                <Day>5</Day>
              </RegistrationDate>
              <OnlineDate>
                <Year>2009</Year>
                <Month>3</Month>
                <Day>23</Day>
              </OnlineDate>
            </ChapterHistory>
            <ChapterGrants Type="Regular"><MetadataGrant Grant="OpenAccess"/><AbstractGrant Grant="OpenAccess"/><BodyPDFGrant Grant="Restricted"/><BodyHTMLGrant Grant="Restricted"/><BibliographyGrant Grant="Restricted"/><ESMGrant Grant="Restricted"/></ChapterGrants><ChapterContext>
              <SeriesID>7651</SeriesID>
              <PartID>2</PartID>
              <BookID>978-1-60327-931-4</BookID>
              <BookTitle>Neural Cell Transplantation</BookTitle>
            </ChapterContext>
          </ChapterInfo>
          <ChapterHeader>
            <AuthorGroup>
              <Author AffiliationIDS="Aff1_9">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Jennifer</GivenName>
                  <GivenName>D.</GivenName>
                  <FamilyName>Newcomb</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1_9">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Alison</GivenName>
                  <GivenName>E.</GivenName>
                  <FamilyName>Willing</FamilyName>
                </AuthorName>
              </Author>
              <Author AffiliationIDS="Aff1_9" CorrespondingAffiliationID="Aff1_9">
                <AuthorName DisplayOrder="Western">
                  <GivenName>Paul</GivenName>
                  <GivenName>R.</GivenName>
                  <FamilyName>Sanberg</FamilyName>
                </AuthorName>
                <Contact>
                  <Email>psanberg@health.usf.edu</Email>
                </Contact>
              </Author>
              <Affiliation ID="Aff1_9">
                <OrgDivision>Department of Neurosurgery, Center of Excellence for Aging and Brain Repair</OrgDivision>
                <OrgName>University of South Florida College of Medicine</OrgName>
                <OrgAddress>
                  <Street>12901 Bruce B Downs Blvd</Street>
                  <Postcode>MDC 78</Postcode>
                  <City>Tampa</City>
                  <State>FL</State>
                  <Postbox>33612</Postbox>
                  <Country>USA</Country>
                </OrgAddress>
              </Affiliation>
            </AuthorGroup>
            <Abstract ID="Abs1_9" Language="En" OutputMedium="All">
              <Heading>Summary</Heading>
              <Para>The umbilical cord of a healthy neonate contains within it a multipotential treatment for a myriad of diseases and injuries. What was once tossed into the biohazard waste without a second thought is now known to be a goldmine of antigenically immature cells that rival the use of bone marrow for reconstitution of blood lineages. Umbilical cord blood (UCB) is emerging as an effective and feasible clinical treatment as its availability increases and benefits are realized. Basic science research has demonstrated a broad therapeutic capacity ranging from cell replacement to cell protection and anti-inflammation in a number of animal disease and injury models. UCB is easily obtained with no harm to infant or mother and can be stored at cryogenic temperatures with relatively little loss of cells upon thaw. The heterogeneous mononuclear fraction has been identified and characterized and transplanted both locally and systemically to treat animal models of stroke, myocardial infarction, Amytrophic Lateral Sclerosis, San Filippo, spinal cord injury, traumatic brain injury, and age-related neurodegeneration, among others. In the pages to follow, we share protocols for the identification and research use of the mononuclear cell fraction of UCB.</Para>
            </Abstract>
            <KeywordGroup Language="En">
              <Heading>
                <Emphasis Type="Bold">Key words</Emphasis>
              </Heading>
              <Keyword>Umbilical cord blood</Keyword>
              <Keyword>Hematopoietic progenitor cell</Keyword>
              <Keyword>Mononuclear cell isolation</Keyword>
              <Keyword>Immunocytochemistry</Keyword>
              <Keyword>Flow cytometry</Keyword>
              <Keyword>UCB transplantation</Keyword>
            </KeywordGroup>
          </ChapterHeader>
          <Body>
            <Section1 ID="Sec1_9">
              <Heading>Introduction</Heading>
              <Para>Tight government restrictions, which limit the availability and use of fetal and embryonic tissue, have prompted the pursuit for alternative sources of stem/progenitor cells. Currently, the clinical use of hematopoietic cells (HPC) derived from bone marrow (BM) is the gold standard treatment for malignant and nonmalignant blood diseases after myeloablative therapy (<CitationRef CitationID="CR1_9">1</CitationRef>, <CitationRef CitationID="CR2_9">2</CitationRef>). However, use of BM has a number of logistical disadvantages that keep it from widespread use including inability to store cryogenically, difficult and invasive collection methods, high incidence of graft-vs.-host-disease (GvHD), and stringent human leukocyte antigen (HLA)-matching requirements to prevent graft rejection. Research continues to reveal that umbilical cord blood (UCB) use can circumvent these complexities and has a potentially unrivaled degree of plasticity. What used to be a biological waste product is now seen as a source of therapeutic cells that have the capabi-lity to treat a number of diseases and injuries. New parents now have the option to take an active role in treating future illness much like a biological insurance policy. Although, much of the currently banked UCB lies in wait for science to catch up with its theoretical curative capability, since 1988 UCB has saved and extended the life of more than 60,000 people worldwide suffering from hematopoietic malignancies, marrow failure, and immunodeficiency disorders (<CitationRef CitationID="CR2_9">2</CitationRef>–<CitationRef CitationID="CR7_9">7</CitationRef>). UCB treatment becoming a clinical standard will require more efficient storage, recovery and expansion techniques, and a more thorough understanding of its mechanisms of action to ensure patient safety. Additionally, with more than 4 million babies born every year in the US alone, a campaign to educate future parents of the benefits of banking their newborn’s cord blood or donating it will make its availability limitless. Here we provide protocols for the research use of UCB cells from isolation and storage to transplantation into animal models of disease. Each protocol herein is a standard in our research group and has been extensively tested for validity and reliability.</Para>
            </Section1>
            <Section1 ID="Sec2_9">
              <Heading>Materials</Heading>
              <Section2 ID="Sec3_9">
                <Heading>Isolation and Cryopreservation of Cord Blood Mononuclear Cells</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>Sterile Phosphate Buffered Saline (PBS).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>Lymphocyte Separation Medium (LSM, Ficoll-hypaque; Sigma).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>RPMI-1640 (Sigma).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para>Dimethyl Sulfoxide (DMSO).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>5.</ItemNumber>
                      <ItemContent>
                        <Para>Fetal Bovine Serum (FBS).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>6.</ItemNumber>
                      <ItemContent>
                        <Para>Sterile 2 ml Cryovials (Nalgene).</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
              <Section2 ID="Sec4_9">
                <Heading>Immunocytochemistry of Cultured Umbilical Cord Blood Cells</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>Dulbecco’s Modified Eagle’s medium (DMEM, Gibco).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>FBS.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>Gentamicin (Sigma).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para>4% paraformaldehyde in 0.1 M PBS.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>5.</ItemNumber>
                      <ItemContent>
                        <Para>Appropriate normal serum.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>6.</ItemNumber>
                      <ItemContent>
                        <Para>Triton X100.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>7.</ItemNumber>
                      <ItemContent>
                        <Para>Primary antibodies of interest.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>8.</ItemNumber>
                      <ItemContent>
                        <Para>Appropriate secondary antibodies.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>9.</ItemNumber>
                      <ItemContent>
                        <Para>Vectashield mounting medium with DAPI (Vector Laboratories).</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
              <Section2 ID="Sec5_9">
                <Heading>Multicolor Flow Cytometry</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>Cold sterile PBS.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>Trypan Blue dye (Gibco).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>Bovine serum albumin (BSA).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para>Human serum.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>5.</ItemNumber>
                      <ItemContent>
                        <Para>Fluorochrome-conjugated antibody(s) of interest.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>6.</ItemNumber>
                      <ItemContent>
                        <Para>DAPI (Sigma).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>7.</ItemNumber>
                      <ItemContent>
                        <Para>FLOWJO flow cytometric analysis software (Tree Star, Inc.).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>8.</ItemNumber>
                      <ItemContent>
                        <Para>LSRII Flow Cytometer (BD).</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
              <Section2 ID="Sec6_9">
                <Heading>UCB Migration to Injured Brain Extracts</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>Liquid nitrogen.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>Clear DMEM (Gibco).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>0.22-μm filters (Millipore).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para>FBS.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>5.</ItemNumber>
                      <ItemContent>
                        <Para>Gentamicin.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>6.</ItemNumber>
                      <ItemContent>
                        <Para>Low-adherence 6-well culture dishes (Corning).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>7.</ItemNumber>
                      <ItemContent>
                        <Para>Trypan Blue dye.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>8.</ItemNumber>
                      <ItemContent>
                        <Para>96-well Chemotax® Chamber plate (Neuro Probe).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>9.</ItemNumber>
                      <ItemContent>
                        <Para>Cell viability assay (CellTiter-Glo Kit, Promega).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>10.</ItemNumber>
                      <ItemContent>
                        <Para>Automated plate reader (Synergy, BioTek).</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
              <Section2 ID="Sec7_9">
                <Heading>UCB Cell Preparation and I.V. Transplantation</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>Sterile PBS pH 7.4.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>1 M HEPES (Sigma).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>Deoxyribonuclease I (DNase; Sigma).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para>Trypan Blue dye.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>5.</ItemNumber>
                      <ItemContent>
                        <Para>Isoflurane (Henry Schein Co.).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>6.</ItemNumber>
                      <ItemContent>
                        <Para>5-0 Silk suture.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>7.</ItemNumber>
                      <ItemContent>
                        <Para>26-gauge and 31-gauge needles.</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
              <Section2 ID="Sec8_9">
                <Heading>UCB Cell Preparation and Local Delivery Using Stereotaxis</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>Isolyte S, pH 7.4 (<Emphasis Type="Italic">see</Emphasis>
                          <Emphasis Type="Bold">Note</Emphasis>
                          <InternalRef RefID="Sec31_9">1</InternalRef>).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>Isoflurane.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>Stereotaxic frame (Kopf).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para>10-μl Hamilton syringe.</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
              <Section2 ID="Sec9_9">
                <Heading>Organotypic Hippocampal Culture</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>DMEM.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>Horse serum (Vector Laboratories).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>Hank’s Balanced Salt Solution (HBSS; Gibco).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para>Glucose.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>5.</ItemNumber>
                      <ItemContent>
                        <Para>Glutamine.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>6.</ItemNumber>
                      <ItemContent>
                        <Para>Glucose-free DMEM (Gibco).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>7.</ItemNumber>
                      <ItemContent>
                        <Para>Propidium iodide (PI; Pharmingen).</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
              <Section2 ID="Sec10_9">
                <Heading>Flow Cytometry for Brain Homogenates</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>HBSS.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>BSA.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>EDTA (BDH).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para>DNase.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>5.</ItemNumber>
                      <ItemContent>
                        <Para>40-μm nylon cell strainers (BD).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>6.</ItemNumber>
                      <ItemContent>
                        <Para>Percoll (Gibco).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>7.</ItemNumber>
                      <ItemContent>
                        <Para>PBS.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>8.</ItemNumber>
                      <ItemContent>
                        <Para>FBS.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>9.</ItemNumber>
                      <ItemContent>
                        <Para>Fc block™ (BD Pharmingen).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>10.</ItemNumber>
                      <ItemContent>
                        <Para>Fluorochrome-conjugated antibody(s) of interest.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>11.</ItemNumber>
                      <ItemContent>
                        <Para>LSRII or FACScaliber flow cytometers (BD).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>12.</ItemNumber>
                      <ItemContent>
                        <Para>FLOWJO software (Tree Star, Inc.).</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
            </Section1>
            <Section1 ID="Sec11_9">
              <Heading>Methods</Heading>
              <Para>Unlike BM, and other HPC sources, UCB cells retain high viability after being kept at cryogenic temperatures until need arises. There are many techniques for volume reduction and cryopreserving these cells (<CitationRef CitationID="CR8_9">8</CitationRef>–<CitationRef CitationID="CR17_9">17</CitationRef>), however, for FDA approval of a cell therapy the volume reduction and MNC isolation must be done in a closed system, free of operator error and contamination (<CitationRef CitationID="CR18_9">18</CitationRef>–<CitationRef CitationID="CR20_9">20</CitationRef>). For laboratory research purposes, the UCB mononuclear cells are sufficiently prepared in an open or semi-closed system using density gradient separation. The cells can then be frozen in cryoprotectant and stored in liquid nitrogen.</Para>
              <Section2 ID="Sec12_9">
                <Heading>Isolation and Cryopreservation of Cord Blood Mononuclear Cells MNC Isolation and Cryopreservation</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>Add 10 ml of sterile PBS to 25-ml fresh UCB in a 50-ml conical centrifuge tube and then invert the tube several times to mix.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>Carefully underlay each tube with 12 ml LSM and centrifuge at 400 × <Emphasis Type="Italic">g</Emphasis> for 30 min.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>After centrifugation the mononuclear cell layer should be easily distinguishable at the interface of plasma and Ficoll. Remove the plasma.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para>Using a 10-ml sterile automatic pipette remove the mononuclear layer to just above the red cell layer.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>5.</ItemNumber>
                      <ItemContent>
                        <Para>Place the cells in a sterile 50-ml conical centrifuge tube and add RPMI-1640 to 45 ml (approximately a 1:2 dilution).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>6.</ItemNumber>
                      <ItemContent>
                        <Para>Centrifuge at 400 × <Emphasis Type="Italic">g</Emphasis> for 15 min.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>7.</ItemNumber>
                      <ItemContent>
                        <Para>Decant the supernatant being careful not to disturb the cell pellet.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>8.</ItemNumber>
                      <ItemContent>
                        <Para>Consolidate all of the tubes into one 50-ml conical centrifuge tube and add RPMI-1640 to 45 ml.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>9.</ItemNumber>
                      <ItemContent>
                        <Para>Centrifuge at 400 × <Emphasis Type="Italic">g</Emphasis> for 15 min.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>10.</ItemNumber>
                      <ItemContent>
                        <Para>Decant supernatant and transfer cell pellet to a 15-ml conical centrifuge tube and add RPMI-1640 to 14 ml. Mix gently by inversion.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>11.</ItemNumber>
                      <ItemContent>
                        <Para>Centrifuge at 400 × <Emphasis Type="Italic">g</Emphasis> for 10 min.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>12.</ItemNumber>
                      <ItemContent>
                        <Para>Discard supernatant and add 2-ml RPMI-1640. Mix carefully using a sterile transfer pipette and transfer to a sterile 5-ml cryotube.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>13.</ItemNumber>
                      <ItemContent>
                        <Para>Prepare the suspension of cord blood at 10<Superscript>6</Superscript> cells/ml with 10% DMSO and FBS by slowly adding the freezing medium to the tube while gently shaking.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>14.</ItemNumber>
                      <ItemContent>
                        <Para>Aliquot 2 ml of the cell suspension to sterile cryovials and store in liquid nitrogen (<Emphasis Type="Italic">see</Emphasis>
                          <Emphasis Type="Bold">Note</Emphasis>
                          <InternalRef RefID="Sec31_9">2</InternalRef>).</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
                <Para>Lymphocytes and monocytes make up the majority of the mononuclear fraction (MNF) of cells in UCB (<CitationRef CitationID="CR21_9">21</CitationRef>). Compared to peripheral blood (PB), UCB has a similar B-lymphocyte population and a lower absolute number of T-lymphocytes (CD3<Superscript>+</Superscript>) but a higher CD4<Superscript>+</Superscript>/CD8<Superscript>+</Superscript> ratio (<CitationRef CitationID="CR21_9">21</CitationRef>, <CitationRef CitationID="CR22_9">22</CitationRef>), as well as, a greater number of NK cells and fewer CD56<Superscript>+</Superscript> cytotoxic T-lymphocytes (<CitationRef CitationID="CR23_9">23</CitationRef>). Additionally, UCB has fewer mature memory T-lymphocytes (CD45RO<Superscript>+</Superscript>) and higher proportions of young CD45RA<Superscript>+</Superscript> cells compared to adult sources (<CitationRef CitationID="CR22_9">22</CitationRef>, <CitationRef CitationID="CR23_9">23</CitationRef>). This lack of antigenicity contributes to UCB’s reduced incidence of GvHD and less stringent donor-recipient matching requirements, leading to a shorter waiting period for treatment (<CitationRef CitationID="CR24_9">24</CitationRef>, <CitationRef CitationID="CR25_9">25</CitationRef>). A more abundant, antigenically naïve, population of hematopoietic stem/progenitor cells found in UCB led to enthusiasm in the neuron replacement therapy research field (<CitationRef CitationID="CR26_9">26</CitationRef>–<CitationRef CitationID="CR32_9">32</CitationRef>). Not only does the MNF contain roughly 1% CD34<Superscript>+</Superscript> cells, a marker designated for its role in early hematopoiesis, but also these cells appear to be more primitive than those found in BM (<CitationRef CitationID="CR33_9">33</CitationRef>, <CitationRef CitationID="CR34_9">34</CitationRef>). Another subset of CD34<Superscript>+</Superscript> cells found in relatively high numbers in UCB are the more primitive CD133<Superscript>+</Superscript> cells. CD133<Superscript>+</Superscript> cells have been identified in fetal brain and in this area are considered to be neural stem cells (NSC) (<CitationRef CitationID="CR25_9">25</CitationRef>, <CitationRef CitationID="CR35_9">35</CitationRef>).</Para>
                <Para>A nonhematopoietic stem cell, the mesenchymal stem cell (MSC), though sparse in comparison to BM, has also been identified in UCB (<CitationRef CitationID="CR36_9">36</CitationRef>, <CitationRef CitationID="CR37_9">37</CitationRef>). The MSC can give rise to such diverse phenotypes as osteoblasts, chondroblasts, adipocytes, hematopoietic, and neural cells (astrocytes and neurons) (<CitationRef CitationID="CR38_9">38</CitationRef>, <CitationRef CitationID="CR39_9">39</CitationRef>). Identifying MSCs is challenging because there is no universal consensus of its phenotypic description. In the literature, MSCs have been defined as being CD13, CD29, CD44, and CD90 positive and CD14, CD31, CD34, CD45, CD51/61, CD64, CD106, and HLA-DR negative (<CitationRef CitationID="CR37_9">37</CitationRef>) as well as CD73, CD90, CD105, and CD166 positive and CD31, CD34, CD45, CD80, and HLA-DR negative (<CitationRef CitationID="CR40_9">40</CitationRef>). Agreement on the phenotype of these cells needs to first be reached before their true abundance in UCB can be known. Regardless, there is a general consensus that there are far fewer MSCs in UCB compared to BM (<CitationRef CitationID="CR41_9">41</CitationRef>).</Para>
                <Para>There are a number of ways to characterize the cells within UCB. Our group routinely uses culture methods to label individual cells immunocytochemically (                           <InternalRef RefID="Tab1">Table 1</InternalRef>). Flow cytometry is also an important tool in characterizing single cell suspensions. This technology can analyze multiple cell properties very quickly and provide objective quantitative results which compliment immunocytochemical methods.<Table Float="Yes" ID="Tab1">
                    <Caption Language="En">
                      <CaptionNumber>Table 1</CaptionNumber>
                      <CaptionContent>
                        <SimplePara>Immunocytochemistry</SimplePara>
                      </CaptionContent>
                    </Caption>
                    <tgroup cols="5">
                      <colspec colname="c0" colnum="0"/>
                      <colspec colname="c1" colnum="1"/>
                      <colspec colname="c2" colnum="2"/>
                      <colspec colname="c3" colnum="3"/>
                      <colspec colname="c4" colnum="4"/>
                      <thead>
                        <row>
                          <entry colname="c0">
                            <SimplePara>Antibody</SimplePara>
                          </entry>
                          <entry colname="c1">
                            <SimplePara>Raised in manufacturer</SimplePara>
                          </entry>
                          <entry colname="c2"/>
                          <entry colname="c3">
                            <SimplePara>Dilution</SimplePara>
                          </entry>
                          <entry colname="c4">
                            <SimplePara>Notes</SimplePara>
                          </entry>
                        </row>
                      </thead>
                      <tbody>
                        <row>
                          <entry colname="c0">
                            <SimplePara>CD3</SimplePara>
                          </entry>
                          <entry colname="c1">
                            <SimplePara>Mouse</SimplePara>
                          </entry>
                          <entry colname="c2">
                            <SimplePara>BD Pharmingen</SimplePara>
                          </entry>
                          <entry colname="c3">
                            <SimplePara>1:50</SimplePara>
                          </entry>
                          <entry colname="c4">
                            <SimplePara>T-lymphocytes</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry colname="c0">
                            <SimplePara>CD4</SimplePara>
                          </entry>
                          <entry colname="c1">
                            <SimplePara>Mouse</SimplePara>
                          </entry>
                          <entry colname="c2">
                            <SimplePara>BD Pharmingen</SimplePara>
                          </entry>
                          <entry colname="c3">
                            <SimplePara>1:50</SimplePara>
                          </entry>
                          <entry colname="c4">
                            <SimplePara>Helper/inducer T-lymphocytes</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry colname="c0">
                            <SimplePara>CD8</SimplePara>
                          </entry>
                          <entry colname="c1">
                            <SimplePara>Mouse</SimplePara>
                          </entry>
                          <entry colname="c2">
                            <SimplePara>BD Pharmingen</SimplePara>
                          </entry>
                          <entry colname="c3">
                            <SimplePara>1:50</SimplePara>
                          </entry>
                          <entry colname="c4">
                            <SimplePara>Cytotoxic/suppressor T-lymphocytes</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry colname="c0">
                            <SimplePara>CD11b</SimplePara>
                          </entry>
                          <entry colname="c1">
                            <SimplePara>Mouse</SimplePara>
                          </entry>
                          <entry colname="c2">
                            <SimplePara>BD Pharmingen</SimplePara>
                          </entry>
                          <entry colname="c3">
                            <SimplePara>1:50</SimplePara>
                          </entry>
                          <entry colname="c4">
                            <SimplePara>Granulocytes, monocytes, NK cells</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry colname="c0">
                            <SimplePara>CD14</SimplePara>
                          </entry>
                          <entry colname="c1">
                            <SimplePara>Mouse</SimplePara>
                          </entry>
                          <entry colname="c2">
                            <SimplePara>BD Pharmingen</SimplePara>
                          </entry>
                          <entry colname="c3">
                            <SimplePara>1:50</SimplePara>
                          </entry>
                          <entry colname="c4">
                            <SimplePara>Monocytes</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry colname="c0">
                            <SimplePara>CD19</SimplePara>
                          </entry>
                          <entry colname="c1">
                            <SimplePara>Mouse</SimplePara>
                          </entry>
                          <entry colname="c2">
                            <SimplePara>BD Pharmingen</SimplePara>
                          </entry>
                          <entry colname="c3">
                            <SimplePara>1:50</SimplePara>
                          </entry>
                          <entry colname="c4">
                            <SimplePara>B-lymphocytes</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry colname="c0">
                            <SimplePara>CD34</SimplePara>
                          </entry>
                          <entry colname="c1">
                            <SimplePara>Mouse</SimplePara>
                          </entry>
                          <entry colname="c2">
                            <SimplePara>BD Pharmingen</SimplePara>
                          </entry>
                          <entry colname="c3">
                            <SimplePara>1:50</SimplePara>
                          </entry>
                          <entry colname="c4">
                            <SimplePara>Hematopoietic progenitors</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry colname="c0">
                            <SimplePara>CD44</SimplePara>
                          </entry>
                          <entry colname="c1">
                            <SimplePara>Mouse</SimplePara>
                          </entry>
                          <entry colname="c2">
                            <SimplePara>BD Pharmingen</SimplePara>
                          </entry>
                          <entry colname="c3">
                            <SimplePara>1:50</SimplePara>
                          </entry>
                          <entry colname="c4">
                            <SimplePara>Hematopoietic cellular adhesion molecule</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry colname="c0">
                            <SimplePara>CD45</SimplePara>
                          </entry>
                          <entry colname="c1">
                            <SimplePara>Mouse</SimplePara>
                          </entry>
                          <entry colname="c2">
                            <SimplePara>BD Pharmingen</SimplePara>
                          </entry>
                          <entry colname="c3">
                            <SimplePara>1:50</SimplePara>
                          </entry>
                          <entry colname="c4">
                            <SimplePara>Common leukocytes</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry colname="c0">
                            <SimplePara>CD117</SimplePara>
                          </entry>
                          <entry colname="c1">
                            <SimplePara>Mouse</SimplePara>
                          </entry>
                          <entry colname="c2">
                            <SimplePara>BD Pharmingen</SimplePara>
                          </entry>
                          <entry colname="c3">
                            <SimplePara>1:50</SimplePara>
                          </entry>
                          <entry colname="c4">
                            <SimplePara>Progenitor cells</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry colname="c0">
                            <SimplePara>CD133</SimplePara>
                          </entry>
                          <entry colname="c1">
                            <SimplePara>Mouse</SimplePara>
                          </entry>
                          <entry colname="c2">
                            <SimplePara>BD Pharmingen</SimplePara>
                          </entry>
                          <entry colname="c3">
                            <SimplePara>1:50</SimplePara>
                          </entry>
                          <entry colname="c4">
                            <SimplePara>Stem cells</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry colname="c0">
                            <SimplePara>Human nuclei (hNuc)</SimplePara>
                          </entry>
                          <entry colname="c1">
                            <SimplePara>Mouse</SimplePara>
                          </entry>
                          <entry colname="c2">
                            <SimplePara>Chemicon</SimplePara>
                          </entry>
                          <entry colname="c3">
                            <SimplePara>1:30</SimplePara>
                          </entry>
                          <entry colname="c4">
                            <SimplePara>Nuclei</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry colname="c0">
                            <SimplePara>Human mito-chondria</SimplePara>
                          </entry>
                          <entry colname="c1">
                            <SimplePara>Mouse</SimplePara>
                          </entry>
                          <entry colname="c2">
                            <SimplePara>Chemicon</SimplePara>
                          </entry>
                          <entry colname="c3">
                            <SimplePara>1:30</SimplePara>
                          </entry>
                          <entry colname="c4">
                            <SimplePara>Mitochondria</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry colname="c0">
                            <SimplePara>TUJ1</SimplePara>
                          </entry>
                          <entry colname="c1">
                            <SimplePara>Rabbit</SimplePara>
                          </entry>
                          <entry colname="c2">
                            <SimplePara>Covance</SimplePara>
                          </entry>
                          <entry colname="c3">
                            <SimplePara>1:1000</SimplePara>
                          </entry>
                          <entry colname="c4">
                            <SimplePara>Early neuronal marker</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry colname="c0">
                            <SimplePara>MAP2</SimplePara>
                          </entry>
                          <entry colname="c1">
                            <SimplePara>Rabbit</SimplePara>
                          </entry>
                          <entry colname="c2">
                            <SimplePara>Chemicon</SimplePara>
                          </entry>
                          <entry colname="c3">
                            <SimplePara>1:1000</SimplePara>
                          </entry>
                          <entry colname="c4">
                            <SimplePara>Neuronal cytoskeleton protein</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry colname="c0">
                            <SimplePara>GFAP</SimplePara>
                          </entry>
                          <entry colname="c1">
                            <SimplePara>Rabbit</SimplePara>
                          </entry>
                          <entry colname="c2">
                            <SimplePara>Dako</SimplePara>
                          </entry>
                          <entry colname="c3">
                            <SimplePara>1:500</SimplePara>
                          </entry>
                          <entry colname="c4">
                            <SimplePara>Astrocytes</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry colname="c0">
                            <SimplePara>Nestin</SimplePara>
                          </entry>
                          <entry colname="c1">
                            <SimplePara>Mouse</SimplePara>
                          </entry>
                          <entry colname="c2">
                            <SimplePara>BD Transduction</SimplePara>
                          </entry>
                          <entry colname="c3">
                            <SimplePara>1:100</SimplePara>
                          </entry>
                          <entry colname="c4">
                            <SimplePara>Early neuronal marker</SimplePara>
                          </entry>
                        </row>
                        <row>
                          <entry colname="c0">
                            <SimplePara>Ox6 (MHC II)</SimplePara>
                          </entry>
                          <entry colname="c1">
                            <SimplePara>Mouse</SimplePara>
                          </entry>
                          <entry colname="c2">
                            <SimplePara>Serotec</SimplePara>
                          </entry>
                          <entry colname="c3">
                            <SimplePara>1:300</SimplePara>
                          </entry>
                          <entry colname="c4">
                            <SimplePara>Activated microglia</SimplePara>
                          </entry>
                        </row>
                      </tbody>
                    </tgroup>
                  </Table>
                </Para>
              </Section2>
              <Section2 ID="Sec13_9">
                <Heading>Immunocytochemistry of Cultured Umbilical Cord Blood Cells Identification</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>Thaw cryopreserved UCB cells rapidly in a 37°C water bath (<Emphasis Type="Italic">see</Emphasis>
                          <Emphasis Type="Bold">Note</Emphasis>
                          <InternalRef RefID="Sec31_9">3</InternalRef>).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>Suspend the cells in DMEM with 10% FBS and 0.1% Gentamicin.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>Plate cells in either 4-well plates or 100-mm dishes at a density of 100,000 cells/cm<Superscript>2</Superscript>.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para>Cells can then be incubated at 37°C in 5% CO<Subscript>2</Subscript>. If the cells are kept for longer than 4 days they will need fresh medium added.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>5.</ItemNumber>
                      <ItemContent>
                        <Para>Prior to immunolabeling, fix the cultures with 4% paraformaldehyde in 0.1 M PBS for 10 min and then wash with PBS three times.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>6.</ItemNumber>
                      <ItemContent>
                        <Para>Block the fixed cells with the appropriate 10% normal serum and 1% Triton X100 in PBS for 1 h at room temperature.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>7.</ItemNumber>
                      <ItemContent>
                        <Para>Incubate the cells in primary antibody for 24 h at 4°C (for a list of our commonly used antibodies and their working dilutions <Emphasis Type="Italic">see</Emphasis>
                          <Emphasis Type="Bold">Table</Emphasis>
                          <InternalRef RefID="Tab1">1</InternalRef>).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>8.</ItemNumber>
                      <ItemContent>
                        <Para>Wash the cells three times for 10 min in PBS.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>9.</ItemNumber>
                      <ItemContent>
                        <Para>Incubate in the appropriate secondary antibody for 2 h at room temperature.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>10.</ItemNumber>
                      <ItemContent>
                        <Para>Nuclei can be visualized by counterstaining the nucleus using Vectashield mounting medium with DAPI.</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
              <Section2 ID="Sec14_9">
                <Heading>Multicolor Flow Cytometry (See Note 4)</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>Thaw cells rapidly at 37°C and wash two times in cold sterile PBS.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>Determine viability using Trypan Blue dye exclusion method.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>Adjust volume to 10<Superscript>6</Superscript> cells per 100 μl buffer (cold sterile PBS with 1% BSA) in 1.5-ml microcentrifuge tubes.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para>Block Fc receptors with 10% human serum in PBS for 20 min.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>5.</ItemNumber>
                      <ItemContent>
                        <Para>Add fluorochrome-conjugated antibodies (<Emphasis Type="Italic">see</Emphasis>
                          <Emphasis Type="Bold">Note</Emphasis>
                          <InternalRef RefID="Sec31_9">5</InternalRef>) and incubate for 30 min.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>6.</ItemNumber>
                      <ItemContent>
                        <Para>Wash cells two times with cold sterile PBS and centrifuge at 150 × g for 5 min.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>7.</ItemNumber>
                      <ItemContent>
                        <Para>Following incubation with antibodies, add 75 μl of 0.35 μg/ml DAPI solution to every 300 μl of cells (approximately 10<Superscript>6</Superscript> cells, scale volume up or down as needed).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>8.</ItemNumber>
                      <ItemContent>
                        <Para>Acquisition can be done on a LSRII flow cytometer.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>9.</ItemNumber>
                      <ItemContent>
                        <Para>Scatter plots and percentages of fluorescent events can be generated using FLOWJO flow cytometric analysis software.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>10.</ItemNumber>
                      <ItemContent>
                        <Para>Using the scatter plots, gate cells based on their morphological characteristics.</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
                <Para>Because of its large population of HPC, UCB was thought to be the ideal source of cells to be used for replacement of dead and/or diseased cells in a number of injuries and diseases. In vivo research has found that human UCB can ameliorate behavioral and physiological consequences in a number of animal disease models, the most exciting of which included diseases and injury of the brain (<CitationRef CitationID="CR42_9">42</CitationRef>–<CitationRef CitationID="CR54_9">54</CitationRef>). Our lab and others have demonstrated UCB’s growth as a multidimensional treatment. The exact mechanisms of action are still unclear but what is apparent is that UCB cells mold their utility to fit their need. New research in our lab has found that UCB may not only act as a cell replacement source, but also as a neurotrophic, neuroprotective, and anti-inflammatory agent. The most notable example of the multifaceted therapeutic effects of UCB is in the MCAO model of embolic stroke. In this rat model, we have achieved profound behavioral improvement and infarct reduction. Stroke involves a complicated cascade of inflammatory events which eventually lead to a pronounced area of cell death adjacent to the blocked vasculature. The inflammatory response to stroke injury has a distinct temporal nature and UCB cells given I.V. 48 h following stroke onset can reverse the injury. The temporal administration of UCB most likely modulates the immune/inflammatory response both peripherally and locally (<CitationRef CitationID="CR43_9">43</CitationRef>–<CitationRef CitationID="CR45_9">45</CitationRef>).</Para>
                <Para>In the complex, highly dynamic living model, neuroprotection and anti-inflammation effects of UCB treatment is difficult to tease apart. We have used an organotypic hippocampal culture system to attempt to define UCB’s neuroprotective potential (<CitationRef CitationID="CR45_9">45</CitationRef>). Inflammatory effects can be studied through ELISA (IL-10, TNF-α, IL-4, IL-1β, and IFNγ) on peripheral blood and homogenates of peripheral immune organs. Flow cytometry can also be done on single cell suspensions of brain and organ recovered from animal models (<CitationRef CitationID="CR45_9">45</CitationRef>). Furthermore, at the immunohistochemical level, we can visualize UCB’s treatment effects using the inflammatory markers GFAP, Ox6 (MCH II), OX42, and CD11b (<Emphasis Type="Italic">see</Emphasis>
                  <Emphasis Type="Bold">Table</Emphasis>
                  <InternalRef RefID="Tab1">
                    <Emphasis Type="Bold">1</Emphasis>
                  </InternalRef> for our antibody dilutions).</Para>
              </Section2>
              <Section2 ID="Sec15_9">
                <Heading>UCB Migration to Injured Brain Extracts Inflammation and Neuroprotection</Heading>
                <Section3 ID="Sec16_9">
                  <Heading>Preparation of Brain Tissue Extracts
(<Emphasis Type="Italic">see</Emphasis>
                    <Emphasis Type="Bold">Note</Emphasis>
                    <InternalRef RefID="Sec31_9">6</InternalRef>)</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Remove brain rapidly and flash-freeze in liquid nitrogen (Store at −80°C until needed).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Partially thaw brain and dissect out regions of interest (e.g., hippocampus, striatum, and/or cortex).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Add 1 ml of clear DMEM for every 150 mg of tissue in a 50-ml conical centrifuge tube and homogenize (<Emphasis Type="Italic">see</Emphasis>
                            <Emphasis Type="Bold">Note</Emphasis>
                            <InternalRef RefID="Sec31_9">7</InternalRef>).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>Centrifuge homogenates at 400 × <Emphasis Type="Italic">g</Emphasis> for 20 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>5.</ItemNumber>
                        <ItemContent>
                          <Para>Collect the supernatant and filter (can be stored at −80°C until needed).</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
                <Section3 ID="Sec17_9">
                  <Heading>Preparation of UCB Cells</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Rapidly thaw cryopreserved UCB cells in a 37°C water bath and add to a 15-ml conical centrifuge tube containing 9 ml of clear DMEM, 5% FBS, and 1 μl/1 ml Gentamicin.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Centrifuge at 400 × g for 15 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Remove supernatant and resuspend cells in 1 ml of media.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>Plate cells in low-adherence 6-well culture dishes and incubate for 24 h at 37°C and 5% CO<Subscript>2.</Subscript>
                          </Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>5.</ItemNumber>
                        <ItemContent>
                          <Para>After 24 h, lift cells by gently pipetting and place in a 15-ml conical centrifuge tube.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>6.</ItemNumber>
                        <ItemContent>
                          <Para>Centrifuge at 400 × <Emphasis Type="Italic">g</Emphasis> for 15 min and resuspend in 1 ml of media without FBS.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>7.</ItemNumber>
                        <ItemContent>
                          <Para>Determine viability using the Trypan Blue dye exclusion method (we only use cells with &gt;80% viability).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>8.</ItemNumber>
                        <ItemContent>
                          <Para>Adjust cell concentration to 62,000 cells per 25 μl media.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
                <Section3 ID="Sec18_9">
                  <Heading>Migration Assay</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Pipette 300 μl of tissue extract (supernatant) into the bottom wells of a 96-well Chemotax® Chamber plate with a 5-μm pore size in triplicate.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Pipette UCB cells (62,000 cells per 25 μl) into the top well.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Incubate migration chamber at 37°C and 5% CO<Subscript>2</Subscript> for 4 h.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>After incubation, remove top plate and centrifuge bottom plate at 300 × <Emphasis Type="Italic">g</Emphasis> for 10 min so that all migrating cells will be forced to the bottom.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>5.</ItemNumber>
                        <ItemContent>
                          <Para>Remove half of the media (150 μl) and determine number of migrated cells using a cell viability assay (<Emphasis Type="Italic">see</Emphasis>
                            <Emphasis Type="Bold">Note</Emphasis>
                            <InternalRef RefID="Sec31_9">8</InternalRef>).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>6.</ItemNumber>
                        <ItemContent>
                          <Para>The migration plate can then be read on an automated plate reader set to luminescence.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                  <Para>Despite our reasonable appreciation of the basic biology of UCB cells we still lack understanding of their dynamics in the living organism. Phenotype means very little if the cells do not function appropriately. Buzanska’s group (<CitationRef CitationID="CR55_9">55</CitationRef>) have shown that the floating population of proliferating cells (CD34<Superscript>−</Superscript>/CD45<Superscript>−</Superscript>) have functioning sodium/potassium channels which respond to exposure to dopa-mine, serotonin, γ-aminobutyric acid, and acetylcholine. This finding further fueled enthusiasm that UCB could become a viable option as a source of transplantable cells that would replace diseased/dead cells. However, the culture dish is far removed from the unique complexities of the biological animal so the next step is to establish that these cells function in vivo. Our group transplanted UCB cells into the subventricular zone of the rat neonate and demonstrated that a handful of cells did differentiate into neurons and glia (<CitationRef CitationID="CR32_9">32</CitationRef>).</Para>
                  <Para>Although it is still unclear whether UCB cells behave the same as phenotypically identical endogenous cells, we do recognize they have an inimitable therapeutic utility beyond replacement of lost cells. UCB cells can ameliorate both motor asymmetry and physiological consequences brought about by middle cerebral artery occlusion in a rat model of stroke (<CitationRef CitationID="CR42_9">42</CitationRef>–<CitationRef CitationID="CR47_9">47</CitationRef>). Early studies demonstrated that some of the transplanted cells expressed the neural antigens NeuN, MAP2, and GFAP indicating that the stroke injury may have led these cells down a neural lineage (<CitationRef CitationID="CR42_9">42</CitationRef>). Interestingly, UCB cells delivered intravenously (I.V.) were more effective in improving long-term outcome than when delivered directly into the affected brain parenchyma postulating an effect on the peripheral immune response to the stroke (<CitationRef CitationID="CR46_9">46</CitationRef>). And, though infiltration of the I.V. administered UCB cells into the brain was minimal, in vitro studies suggest that injured brain does produce chemotactic signals that attract specific cells to the site of injury (<CitationRef CitationID="CR56_9">56</CitationRef>).</Para>
                  <Para>Until recently, UCB cell infusion in our and others’ animal stroke models was arbitrarily set to 24 h following injury. The results from the aforementioned migration assay led to a surprising discovery. UCB cells appeared to have a definite temporal nature to their migration, which in striatal extracts (injured area in MCAO rat models of stroke), was as late as 72 h (<CitationRef CitationID="CR56_9">56</CitationRef>). The clear temporally dependent nature of migration was discovered and led to affirmation that when UCB cells are administered I.V. at a specific time point postinjury onset maximum recovery results in vivo (<CitationRef CitationID="CR43_9">43</CitationRef>). In many cases, stroked animals did not display physiological or behavioral consequences from their injury. It is believed that the peak of the inflammatory response to the injury coincides with the optimal therapeutic window. Moreover, temporal I.V. administration of UCB cells is a more critical determinant of recovery than cell dose based on both behavioral and physiological measures of recovery (<CitationRef CitationID="CR43_9">43</CitationRef>, <CitationRef CitationID="CR44_9">44</CitationRef>).</Para>
                  <Para>Our group employs I.V. delivery of UCB cells in other animal models using the penile, tail, jugular, and femoral veins. Choice of method often depends on ease of administration. In studies where only male animals are used, the penile vein is fast and efficient, requiring minimal anesthesia time and no surgical cut down. Jugular vein delivery is employed in studies utilizing both male and female mice. And, though, I.V. is currently the delivery route of choice in our group, local administration is still required to answer questions of the cells’ direct effect on the brain/injured area.</Para>
                </Section3>
              </Section2>
              <Section2 ID="Sec19_9">
                <Heading>UCB Cell Preparation and I.V. Transplantation In Vivo</Heading>
                <Section3 ID="Sec20_9">
                  <Heading>UCB Cell Preparation</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Rapidly thaw cryopreserved UCB cells in a 37°C water bath.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Transfer thawed cells from cryovial to a 15-ml conical centrifuge tube containing buffer [9.8 ml sterile PBS pH 7.4, 200 μl 1 M HEPES and 500 μl DNase (5 mg/ml)].</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Centrifuge at room temperature at 200 × <Emphasis Type="Italic">g</Emphasis> for 10 min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>Remove supernatant and resuspend cells in 10-ml buffer.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>5.</ItemNumber>
                        <ItemContent>
                          <Para>Repeat <Emphasis Type="Bold">step 4</Emphasis>.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>6.</ItemNumber>
                        <ItemContent>
                          <Para>Resuspend cell pellet in 1-ml buffer and determine viability using the Trypan Blue dye exclusion method.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>7.</ItemNumber>
                        <ItemContent>
                          <Para>Determine cell density needed for injection and prepare desired number of cells in buffer.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
                <Section3 ID="Sec21_9">
                  <Heading>Femoral Vein Infusion</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Anesthetize animal with 3% Isoflurane in O<Subscript>2</Subscript> at 2 l/min.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Shave inside thigh area and prepare using alternating betadine and alcohol scrubs.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Using blunt dissection, isolate the femoral vein.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>Using 5-0 silk suture put a tie on the distal vein to prevent cells from flowing back.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>5.</ItemNumber>
                        <ItemContent>
                          <Para>Introduce a 26-gauge needle attached to a 1-ml syringe containing cell suspension into the lumen of the vein.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>6.</ItemNumber>
                        <ItemContent>
                          <Para>Deliver cells (usually 100–500 μl) over a 5-min period.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>7.</ItemNumber>
                        <ItemContent>
                          <Para>Withdraw the needle and place an additional suture proximal to the hole to prevent bleeding and cells from leaking out.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>8.</ItemNumber>
                        <ItemContent>
                          <Para>Close the incision.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
                <Section3 ID="Sec22_9">
                  <Heading>Tail Vein Infusion</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Anesthetize animal as described above.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Apply a hot compress to the base of the tail to dilate the vein (or run under hot water, taking care not to scald the skin).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Introduce a 26-gauge needle attached to a 1-ml syringe containing the cell suspension into the lumen of the vein and deliver cells as described above.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>Withdraw needle and apply pressure to the point of entry to prevent bleeding.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
                <Section3 ID="Sec23_9">
                  <Heading>Jugular Vein Infusion</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Anesthetize animal and prepare area as described above.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Using blunt dissection, isolate the jugular vein.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Ligate the vein as described in the femoral vein infusion methods and make a small hole in the vessel using a 26-gauge needle.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>Insert a 31-gauge needle attached to a 10-μl Hamilton syringe containing the cell suspension into the hole and suture into place.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>5.</ItemNumber>
                        <ItemContent>
                          <Para>Deliver the cells over a 5-min period.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>6.</ItemNumber>
                        <ItemContent>
                          <Para>Withdraw needle and tighten suture to avoid bleeding and loss of cells and close incision.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
                <Section3 ID="Sec24_9">
                  <Heading>Penile Vein Infusion</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Anesthetize animal as described above.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Expose penile vein and clean area with alcohol.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Introduce a 26-gauge needle attached to a 1-ml syringe containing cell suspension into the lumen of the vein and deliver cells over a 5-min period.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>Withdraw needle and apply pressure to entry site to avoid bleeding and cell loss.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
              </Section2>
              <Section2 ID="Sec25_9">
                <Heading>UCB Cell Preparation and Local Delivery Using Stereotaxis</Heading>
                <Section3 ID="Sec26_9">
                  <Heading>Cell Preparation for Local Cell Delivery</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Thaw cryopreserved cells rapidly in a 37°C water bath.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Wash in Isolyte S, pH 7.4 and centrifuge cells three times (200 × <Emphasis Type="Italic">g</Emphasis> for 10 min).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Determine viability and adjust to desired cell concentration (we use a cell concentration of 100,000 cells/μl).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>Aliquot the suspension into volumes slightly larger than the final desired volume to be delivered (<Emphasis Type="Italic">see</Emphasis>
                            <Emphasis Type="Bold">Note</Emphasis>
                            <InternalRef RefID="Sec31_9">9</InternalRef>).</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
                <Section3 ID="Sec27_9">
                  <Heading>Preparation of Animal for Local Cell Delivery</Heading>
                  <Para>
                    <OrderedList>
                      <ListItem>
                        <ItemNumber>1.</ItemNumber>
                        <ItemContent>
                          <Para>Animals are anesthetized with 3% Isoflurane in O<Subscript>2</Subscript> at 2 l/min and placed in a stereotaxic frame.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>2.</ItemNumber>
                        <ItemContent>
                          <Para>Shave the head and surgically prepare using alternating betadine and alcohol scrubs.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>3.</ItemNumber>
                        <ItemContent>
                          <Para>Make a midline incision with a scalpel and clean away the facia from the skull.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>4.</ItemNumber>
                        <ItemContent>
                          <Para>Make all medial/lateral (ML) and anterior/posterior (AP) measurements from the Bregma landmark and dorsal/ventral (DV) measurements from dura (<Emphasis Type="Italic">see</Emphasis>
                            <Emphasis Type="Bold">Note</Emphasis>
                            <InternalRef RefID="Sec31_9">10</InternalRef>).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>5.</ItemNumber>
                        <ItemContent>
                          <Para>Bore a small hole in the skull with a drill taking care not to drill past the lower extent of the skull.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>6.</ItemNumber>
                        <ItemContent>
                          <Para>With a fine dental pick, carefully place a small hole in the dura for the needle to pass through (<Emphasis Type="Italic">see</Emphasis>
                            <Emphasis Type="Bold">Note</Emphasis>
                            <InternalRef RefID="Sec31_9">11</InternalRef>).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>7.</ItemNumber>
                        <ItemContent>
                          <Para>Load a 10-μl Hamilton syringe with the cell suspension just prior to delivery to prevent cells from clumping.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>8.</ItemNumber>
                        <ItemContent>
                          <Para>Lower the needle into place at the desired coordinates and wait for 2 min to allow the tissue to decompress around the needle.</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>9.</ItemNumber>
                        <ItemContent>
                          <Para>Deliver cells over the course of the next 5 min. Leave the needle in place for an additional 5 min prior to withdrawing slowly (<Emphasis Type="Italic">see</Emphasis>
                            <Emphasis Type="Bold">Note</Emphasis>
                            <InternalRef RefID="Sec31_9">12</InternalRef>).</Para>
                        </ItemContent>
                      </ListItem>
                      <ListItem>
                        <ItemNumber>10.</ItemNumber>
                        <ItemContent>
                          <Para>Close incision with wound clips.</Para>
                        </ItemContent>
                      </ListItem>
                    </OrderedList>
                  </Para>
                </Section3>
              </Section2>
              <Section2 ID="Sec28_9">
                <Heading>Organotypic Hippocampal Culture</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>Isolate the hippocampi and cut into coronal slices (1,000-mm thick).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>Transfer slices into 24 mm-diameter membrane inserts and place into 24-well culture trays with 1.5 ml of medium, consisting of 50% DMEM, 25% heat-in-activated horse serum, and 25% HBSS supplemented with 4.5 mg/ml glucose and 1 mM glutamine, per well.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>Change the media every 2 days for 14 days.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para>Place slices in glucose-free medium and subject to 45 min of hypoxia in a hypoxia chamber (a hypoxic environment is produced in a humidified chamber at 37°C that is prepared by flushing at 8 l/min for 15 min with 1% oxygen, 5% CO<Subscript>2</Subscript>, and 94% nitrogen).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>5.</ItemNumber>
                      <ItemContent>
                        <Para>Following hypoxia, culture an additional 3 days under ischemic conditions (deoxygenated, glucose-free DMEM).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>6.</ItemNumber>
                      <ItemContent>
                        <Para>For the co-culture group, place the membrane inserts with the ischemic hippocampal slices into a well with UCB cells (50,000 cells/ml). For the non-co-culture group, place the hippocampal slices into cell-free media (1 ml per well).</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>7.</ItemNumber>
                      <ItemContent>
                        <Para>Following culture period, stain the cells with PI to identify the dying cells.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>8.</ItemNumber>
                      <ItemContent>
                        <Para>Delineate Hippocampal areas CA1, CA2, and CA3 and the dentate gyrus (DG) and quantify the optical density using a density analyzer program (Image J, NIH, <Emphasis Type="Italic">see</Emphasis>
                          <Emphasis Type="Bold">Note</Emphasis>
                          <InternalRef RefID="Sec31_9">13</InternalRef>).</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
              </Section2>
              <Section2 ID="Sec29_9">
                <Heading>Flow Cytometry for Brain Homogenates</Heading>
                <Para>
                  <OrderedList>
                    <ListItem>
                      <ItemNumber>1.</ItemNumber>
                      <ItemContent>
                        <Para>Remove the brain rapidly, separate the hemispheres and place into ice-cold HBSS containing 0.2% BSA, 0.01 mol/l EDTA, and 10 mg/ml DNase.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>2.</ItemNumber>
                      <ItemContent>
                        <Para>Homogenize the brain tissue and passed through a 40-μm nylon cell strainer.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>3.</ItemNumber>
                      <ItemContent>
                        <Para>Centrifuge the suspension two times at 400 × <Emphasis Type="Italic">g</Emphasis> for 10 min at room temperature.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>4.</ItemNumber>
                      <ItemContent>
                        <Para>Resuspend the pellet in 70% Percoll in BS.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>5.</ItemNumber>
                      <ItemContent>
                        <Para>Overlay suspension with a gradient containing 30% Percoll solution in PBS and centrifuge at 600 × <Emphasis Type="Italic">g</Emphasis> for 45 min at room temperature.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>6.</ItemNumber>
                      <ItemContent>
                        <Para>Collect the cells from the Percoll to PBS interface and wash once with HBSS with 10% FBS.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>7.</ItemNumber>
                      <ItemContent>
                        <Para>Resuspend cells in flow buffer (0.02% BSA, 0.05 mM EDTA in PBS) containing Fc block™ to inhibit nonspecific binding.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>8.</ItemNumber>
                      <ItemContent>
                        <Para>Incubate with appropriate fluorochrome-conjugated antibody(s) (<Emphasis Type="Italic">see</Emphasis>
                          <Emphasis Type="Bold">Note</Emphasis>
                          <InternalRef RefID="Sec31_9">1</InternalRef>) for 60 min in the dark with and on ice.</Para>
                      </ItemContent>
                    </ListItem>
                    <ListItem>
                      <ItemNumber>9.</ItemNumber>
                      <ItemContent>
                        <Para>After incubation with antibody, wash two times with flow cytometry buffer.</Para>
                      </ItemContent>
                    </ListItem>
                  </OrderedList>
                </Para>
                <Para>Acquisition can be performed on the LSRII or FACScaliber flow cytometers and analysis done using FLOWJO software.</Para>
              </Section2>
            </Section1>
            <Section1 ID="Sec30_9">
              <Heading>Conclusion</Heading>
              <Para>All of the research described within this chapter follows a common thread; it attempts to define UCB’s role in recovery from disease and injury. Clearly, UCB works uniquely depending on its environment and the nature of the injury; a presumed molding to fit the need. The multifaceted nature of UCB’s therapeutic effects is no doubt a function of its heterogenous make up, and also is what eludes researchers attempting to classify its benefits. Of course, this is the goal and the necessity before UCB can achieve pervasive use in the clinic, both putting to rest the question of safety and appropriately matching its utility to fit the specific illness. The therapeutic potential of UCB is far reaching from common ailments to exotic diagnoses. Any disease with an inflammatory component or need of neuroprotection may benefit from UCB cell treatment. If discovering its mechanisms of action to ensure safety in its use and perfecting the expansion process is all that remains, then its widespread penetration into hospitals and clinics is inevitable.</Para>
            </Section1>
            <Section1 ID="Sec31_9">
              <Heading>Notes</Heading>
              <Para>
                <OrderedList>
                  <ListItem>
                    <ItemNumber>1.</ItemNumber>
                    <ItemContent>
                      <Para>While Isolyte S, pH 7.4 was the vehicle we used in the initial transplant studies, PBS with HEPE and DNase as described in <Emphasis Type="Bold">Subheading</Emphasis>
                        <InternalRef RefID="Sec20_9">3.5.1</InternalRef> works equally well.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>2.</ItemNumber>
                    <ItemContent>
                      <Para>For best results, the cells should be gradually cooled to −80°C in a freezing container (Nalgene) before placing in liquid nitrogen.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>3.</ItemNumber>
                    <ItemContent>
                      <Para>The vial of cells is only left in the water bath until approximately 95% of the suspension is thawed to minimize the shock of thawing to the cells.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>4.</ItemNumber>
                    <ItemContent>
                      <Para>To maintain cell viability it is crucial that cells be kept cold (preferably on ice) throughout blocking, antibody incubations, and until acquisition on a Flow cytometer. Ideally, samples should be run immediately following <Emphasis Type="Bold">step 7</Emphasis> of the
multicolor Flow Cytometry protocol, but if not practical, can be stored on ice in the dark for up to 2 h.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>5.</ItemNumber>
                    <ItemContent>
                      <Para>Specific concentration of antibody should be determined by titration. Titration is especially important for multiple color flow cytometry where even a small change in buffer volume can dilute an antibody to nonsaturating levels.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>6.</ItemNumber>
                    <ItemContent>
                      <Para>Brain tissue extracts were harvested from rats that underwent middle cerebral artery occlusion (MCAO). For MCAO description, refer to Newcomb et al. (<CitationRef CitationID="CR43_9">43</CitationRef>).</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>7.</ItemNumber>
                    <ItemContent>
                      <Para>It is critical that the media is colorless; otherwise phenol red may interfere with the luminescence readings for cell viability.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>8.</ItemNumber>
                    <ItemContent>
                      <Para>While there is more than one way to measure cell viability, we have found the Promega CellTiter-Glo kit works well in this application.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>9.</ItemNumber>
                    <ItemContent>
                      <Para>The cell suspension is divided into single transplant aliquots for two reasons. First, there is less likelihood of contamination and second, cell viability is maintained longer as the suspension is not being continually mixed and remixed for multiple transplants. Aliquot volume should be greater than the final volume that is to be delivered, allowing for needle/syringe deadspace and testing of delivery prior to transplant.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>10.</ItemNumber>
                    <ItemContent>
                      <Para>Stereotactic coordinates commonly used in our group. (a) Rats. <Emphasis Type="Italic">Striatum</Emphasis> coordinates (delivered into two adjacent sites in our studies): AP 1.2 mm, ML 2.7 mm, DV −5.2 mm, and −4.7 mm. Tooth bar set at zero. <Emphasis Type="Italic">Subventricular zone</Emphasis>: AP 1.6 mm, ML ±1.5 mm, DV −4.2 mm. Tooth bar set at −2.3. <Emphasis Type="Italic">Hippocampus</Emphasis>: AP −3.8 mm, ML ±2.5 mm, DV −1.5 mm. Tooth bar set at −2.3. (b) Mice. <Emphasis Type="Italic">Ventricle</Emphasis>: AP 3.8 mm, ML ±0.8 mm, DV 2.0 mm. Tooth bar set at zero.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>11.</ItemNumber>
                    <ItemContent>
                      <Para>By piercing the dura in advance, there is less damage to cortex from tearing of the dura or compression as the needle moves into the tissue.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>12.</ItemNumber>
                    <ItemContent>
                      <Para>Waiting 5 min prior to withdrawing the needle allows the cell suspension to diffuse away from the needle tip, decreasing the likelihood of pulling the transplanted cells up and out along the needle tract when the needle is withdrawn.</Para>
                    </ItemContent>
                  </ListItem>
                  <ListItem>
                    <ItemNumber>13.</ItemNumber>
                    <ItemContent>
                      <Para>Image J software for image processing and analysis can be downloaded from the NIH Web site: <ExternalRef>
                          <RefSource>http://rsb.info.nih.gov/ij/</RefSource>
                          <RefTarget Address="http://rsb.info.nih.gov/ij/" TargetType="URL"/>
                        </ExternalRef>
                      </Para>
                    </ItemContent>
                  </ListItem>
                </OrderedList>
              </Para>
            </Section1>
          </Body>
          <BodyRef FileRef="BodyRef/PDF/978-1-60327-931-4_Chapter_9.pdf" OutputMedium="Online" PDFType="Typeset" TargetType="OnlinePDF"/>
          <ChapterBackmatter>
            <Acknowledgments>
              <Heading>Acknowledgments</Heading>
              <SimplePara>The authors would like to thank Dr. Svitlana Garbuzova-Davis, Dr. Ning Chen, Dr. Mary Newman, Dr. Nicole Kuzmin-Nichols, and Dr. Martina Vendrame for contributing their protocols. Many of the UCB MNCs used in the above protocols were obtained from Saneron CCEL Therapeutics, Inc. PRS is a cofounder and AEW is a consultant to Saneron CCEL Therapeutics, Inc.</SimplePara>
            </Acknowledgments>
            <Bibliography ID="Bib1_9">
              <Heading>References</Heading>
              <Citation ID="CR1_9">
                <CitationNumber>1.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J.</Initials>
                    <FamilyName>Armitage</FamilyName>
                  </BibAuthorName>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">Bone marrow transplantation</ArticleTitle>
                  <JournalTitle>New Eng. J. Med</JournalTitle>
                  <VolumeID>330</VolumeID>
                  <FirstPage>827</FirstPage>
                  <LastPage>838</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8114836</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1056/NEJM199403243301206</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK2c7lvV2rtQ%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Armitage, J. (1994). Bone marrow transplantation. New Eng. J. Med. 330, 827–838.</BibUnstructured>
              </Citation>
              <Citation ID="CR2_9">
                <CitationNumber>2.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>N.S.</Initials>
                    <FamilyName>El-Badri</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Z.</Initials>
                    <FamilyName>Kazi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P.R.</Initials>
                    <FamilyName>Sanberg</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Stem cell transplantation for hematologic malignancies</ArticleTitle>
                  <JournalTitle>Cell Transplant</JournalTitle>
                  <VolumeID>13</VolumeID>
                  <FirstPage>721</FirstPage>
                  <LastPage>723</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.3727/000000004783983585</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>El-Badri, N.S., Kazi, Z., Sanberg, P.R. (2004). Stem cell transplantation for hematologic malignancies. Cell Transplant. 13, 721–723.</BibUnstructured>
              </Citation>
              <Citation ID="CR3_9">
                <CitationNumber>3.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J.N.</Initials>
                    <FamilyName>Barker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D.J.</Initials>
                    <FamilyName>Weisdorf</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T.E.</Initials>
                    <FamilyName>DeFor</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B.R.</Initials>
                    <FamilyName>Blazar</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P.B.</Initials>
                    <FamilyName>McGlave</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.S.</Initials>
                    <FamilyName>Miller</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C.M.</Initials>
                    <FamilyName>Verfaillie</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.E.</Initials>
                    <FamilyName>Wagner</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy</ArticleTitle>
                  <JournalTitle>Blood</JournalTitle>
                  <VolumeID>105</VolumeID>
                  <FirstPage>1343</FirstPage>
                  <LastPage>1347</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15466923</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1182/blood-2004-07-2717</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Barker, J.N., Weisdorf, D.J., DeFor, T.E., Blazar, B.R., McGlave, P.B., Miller, J.S., Verfaillie, C.M., Wagner, J.E. (2004). Transplantation of 2 partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy. Blood 105, 1343–1347.</BibUnstructured>
              </Citation>
              <Citation ID="CR4_9">
                <CitationNumber>4.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>F.</Initials>
                    <FamilyName>Gluckman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V.</Initials>
                    <FamilyName>Rocha</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">History of the clinical use of umbilical cord blood hematopoietic cells</ArticleTitle>
                  <JournalTitle>Cytotherapy</JournalTitle>
                  <VolumeID>7</VolumeID>
                  <FirstPage>219</FirstPage>
                  <LastPage>227</LastPage>
                  <Occurrence Type="PID">
                    <Handle>16081348</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1080/14653240510027136</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD2MvhslWksg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Gluckman, F., Rocha, V. (2005). History of the clinical use of umbilical cord blood hematopoietic cells. Cytotherapy 7, 219–227.</BibUnstructured>
              </Citation>
              <Citation ID="CR5_9">
                <CitationNumber>5.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M.J.</Initials>
                    <FamilyName>Laughlin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.</Initials>
                    <FamilyName>Barker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B.</Initials>
                    <FamilyName>Bambach</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>O.N.</Initials>
                    <FamilyName>Koc</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D.A.</Initials>
                    <FamilyName>Rizzieri</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.E.</Initials>
                    <FamilyName>Wagner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.L.</Initials>
                    <FamilyName>Gerson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H.M.</Initials>
                    <FamilyName>Lazarus</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Cairo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C.E.</Initials>
                    <FamilyName>Stevens</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P.</Initials>
                    <FamilyName>Rubinstein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.</Initials>
                    <FamilyName>Kurtzberg</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Hematopoietic engraftment and survival in adult recipients of umbilical cord blood from unrelated donors</ArticleTitle>
                  <JournalTitle>New Eng. J. Med</JournalTitle>
                  <VolumeID>344</VolumeID>
                  <FirstPage>1815</FirstPage>
                  <LastPage>1822</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11407342</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1056/NEJM200106143442402</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD3Mzktlyrtw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Laughlin, M.J., Barker, J., Bambach, B., Koc, O.N., Rizzieri, D.A., Wagner, J.E., Gerson, S.L., Lazarus, H.M., Cairo, M., Stevens, C.E., Rubinstein, P., Kurtzberg, J. (2001). Hematopoietic engraftment and survival in adult recipients of umbilical cord blood from unrelated donors. New Eng. J. Med. 344, 1815–1822.</BibUnstructured>
              </Citation>
              <Citation ID="CR6_9">
                <CitationNumber>6.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>W.</Initials>
                    <FamilyName>Tse</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.J.</Initials>
                    <FamilyName>Laughlin</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Umbilical cord blood transplantation: a new alternative option</ArticleTitle>
                  <JournalTitle>Hematol.</JournalTitle>
                  <VolumeID>2005</VolumeID>
                  <IssueID>1</IssueID>
                  <FirstPage>377</FirstPage>
                  <LastPage>383</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1182/asheducation-2005.1.377</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Tse, W., Laughlin, M.J. (2005). Umbilical cord blood transplantation: a new alternative option. Hematol. 2005(1), 377–383.</BibUnstructured>
              </Citation>
              <Citation ID="CR7_9">
                <CitationNumber>7.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J.E.</Initials>
                    <FamilyName>Wagner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H.E.</Initials>
                    <FamilyName>Broxmeyer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R.L.</Initials>
                    <FamilyName>Byrd</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B.</Initials>
                    <FamilyName>Zehnbauer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B.</Initials>
                    <FamilyName>Schmeckpeper</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N.</Initials>
                    <FamilyName>Shah</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C.</Initials>
                    <FamilyName>Griffin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P.D.</Initials>
                    <FamilyName>Emanuel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K.S.</Initials>
                    <FamilyName>Zuckerman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Cooper</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C.</Initials>
                    <FamilyName>Carow</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>W.</Initials>
                    <FamilyName>Bias</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G.W.</Initials>
                    <FamilyName>Santos</FamilyName>
                  </BibAuthorName>
                  <Year>1992</Year>
                  <ArticleTitle Language="En">Transplantation of umbilical cord blood after myeloablative therapy: analysis of engraftment</ArticleTitle>
                  <JournalTitle>Blood</JournalTitle>
                  <VolumeID>79</VolumeID>
                  <FirstPage>1874</FirstPage>
                  <LastPage>1881</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1348434</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK383hs1WjsA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Wagner, J.E., Broxmeyer, H.E., Byrd, R.L., Zehnbauer, B., Schmeckpeper, B., Shah, N., Griffin, C., Emanuel, P.D., Zuckerman, K.S., Cooper, S., Carow, C., Bias, W., Santos, G.W. (1992). Transplantation of umbilical cord blood after myeloablative therapy: analysis of engraftment. Blood 79, 1874–1881.</BibUnstructured>
              </Citation>
              <Citation ID="CR8_9">
                <CitationNumber>8.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M.L.</Initials>
                    <FamilyName>Escolar</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.D.</Initials>
                    <FamilyName>Poe</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.M.</Initials>
                    <FamilyName>Provenzale</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K.C.</Initials>
                    <FamilyName>Richards</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.</Initials>
                    <FamilyName>Allison</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Wood</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D.A.</Initials>
                    <FamilyName>Wenger</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D.</Initials>
                    <FamilyName>Pietryga</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D.</Initials>
                    <FamilyName>Wall</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Champagne</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R.</Initials>
                    <FamilyName>Morse</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>W.</Initials>
                    <FamilyName>Krivit</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.</Initials>
                    <FamilyName>Kurtzberg</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Transplantation of umbilical-cord blood in babies with infantile Krabbe’s disease</ArticleTitle>
                  <JournalTitle>N. Eng. J. Med</JournalTitle>
                  <VolumeID>352</VolumeID>
                  <FirstPage>2069</FirstPage>
                  <LastPage>2081</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1056/NEJMoa042604</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXkt1Kltrg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Escolar, M.L., Poe, M.D., Provenzale, J.M., Richards, K.C., Allison, J., Wood, S., Wenger, D.A., Pietryga, D., Wall, D., Champagne, M., Morse, R., Krivit, W., Kurtzberg, J. (2005). Transplantation of umbilical-cord blood in babies with infantile Krabbe’s disease. N. Eng. J. Med. 352, 2069–2081.</BibUnstructured>
              </Citation>
              <Citation ID="CR9_9">
                <CitationNumber>9.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>G.</Initials>
                    <FamilyName>Fujisaki</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Kami</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y.</Initials>
                    <FamilyName>Kishi</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Cord-blood transplants from unrelated donor in Hurler’s syndrome</ArticleTitle>
                  <JournalTitle>N. Eng. J. Med</JournalTitle>
                  <VolumeID>351</VolumeID>
                  <FirstPage>506</FirstPage>
                  <LastPage>507</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1056/NEJM200407293510518</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXmtFaktb8%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Fujisaki, G., Kami, M., Kishi, Y. (2004). Cord-blood transplants from unrelated donor in Hurler’s syndrome. N. Eng. J. Med. 351, 506–507.</BibUnstructured>
              </Citation>
              <Citation ID="CR10_9">
                <CitationNumber>10.</CitationNumber>
                <BibUnstructured>NMDP (1999). Cord Blood Bank Standard Operating Procedures. National Marrow Donor Program &amp; National Heart, Lung, and Blood Institute.</BibUnstructured>
              </Citation>
              <Citation ID="CR11_9">
                <CitationNumber>11.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>G.</Initials>
                    <FamilyName>Kögler</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.</Initials>
                    <FamilyName>Sarnowski</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P.</Initials>
                    <FamilyName>Wernet</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Volume reduction of cord blood by Hetastarch for long-term stem cell banking</ArticleTitle>
                  <JournalTitle>Bone Marrow Transplant.</JournalTitle>
                  <VolumeID>22</VolumeID>
                  <IssueID>Suppl 1</IssueID>
                  <FirstPage>S14</FirstPage>
                  <LastPage>S15</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9715874</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kögler, G., Sarnowski, A., Wernet, P. (1998). Volume reduction of cord blood by Hetastarch for long-term stem cell banking. Bone Marrow Transplant. 22(Suppl 1), S14–S15.</BibUnstructured>
              </Citation>
              <Citation ID="CR12_9">
                <CitationNumber>12.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P.</Initials>
                    <FamilyName>Rubinstein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L.</Initials>
                    <FamilyName>Dobrila</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R.E.</Initials>
                    <FamilyName>Rosenfield</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.W.</Initials>
                    <FamilyName>Adamson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G.</Initials>
                    <FamilyName>Migliaccio</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.R.</Initials>
                    <FamilyName>Migliaccio</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P.E.</Initials>
                    <FamilyName>Taylor</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C.E.</Initials>
                    <FamilyName>Stevens</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution</ArticleTitle>
                  <JournalTitle>Proc. Natl Acad. Sci. USA</JournalTitle>
                  <VolumeID>92</VolumeID>
                  <IssueID>22</IssueID>
                  <FirstPage>10119</FirstPage>
                  <LastPage>10122</LastPage>
                  <Occurrence Type="PID">
                    <Handle>7479737</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.92.22.10119</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK2MXovFalsrs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Rubinstein, P., Dobrila, L., Rosenfield, R.E., Adamson, J.W., Migliaccio, G., Migliaccio, A.R., Taylor, P.E., Stevens, C.E. (1995). Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. Proc. Natl Acad. Sci. USA 92(22), 10119–10122.</BibUnstructured>
              </Citation>
              <Citation ID="CR13_9">
                <CitationNumber>13.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P.</Initials>
                    <FamilyName>Perutelli</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Catellani</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L.</Initials>
                    <FamilyName>Scarso</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P.</Initials>
                    <FamilyName>Cornaglia-Ferraris</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G.</Initials>
                    <FamilyName>Dini</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Processing of human cord blood by three different procedures for red blood cell depletion and mononuclear cell recovery</ArticleTitle>
                  <JournalTitle>Vox Sang.</JournalTitle>
                  <VolumeID>76</VolumeID>
                  <IssueID>4</IssueID>
                  <FirstPage>237</FirstPage>
                  <LastPage>240</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10394144</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1046/j.1423-0410.1999.7640237.x</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1MXktFeltLc%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Perutelli, P., Catellani, S., Scarso, L., Cornaglia-Ferraris, P., Dini, G. (1999). Processing of human cord blood by three different procedures for red blood cell depletion and mononuclear cell recovery. Vox Sang. 76(4), 237–240.</BibUnstructured>
              </Citation>
              <Citation ID="CR14_9">
                <CitationNumber>14.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>W.</Initials>
                    <FamilyName>Schwinger</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Benesch</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H.</Initials>
                    <FamilyName>Lackner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R.</Initials>
                    <FamilyName>Kerbl</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Walcher</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C.</Initials>
                    <FamilyName>Urban</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Comparison of different methods for separation and <Emphasis Type="Italic">ex vivo</Emphasis> expansion of cord blood progenitor cells</ArticleTitle>
                  <JournalTitle>Ann. Hematol.</JournalTitle>
                  <VolumeID>78</VolumeID>
                  <IssueID>8</IssueID>
                  <FirstPage>364</FirstPage>
                  <LastPage>370</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10460350</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1007/s002770050530</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK1MzovFGqsg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Schwinger, W., Benesch, M., Lackner, H., Kerbl, R., Walcher, M., Urban, C. (1999). Comparison of different methods for separation and <Emphasis Type="Italic">ex vivo</Emphasis> expansion of cord blood progenitor cells. Ann. Hematol. 78(8), 364–370.</BibUnstructured>
              </Citation>
              <Citation ID="CR15_9">
                <CitationNumber>15.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>C.</Initials>
                    <FamilyName>Almici</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C.</Initials>
                    <FamilyName>Carlo-Stella</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L.</Initials>
                    <FamilyName>Mangoni</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D.</Initials>
                    <FamilyName>Garau</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L.</Initials>
                    <FamilyName>Cottafavi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.</Initials>
                    <FamilyName>Ventura</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Armanetti</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.E.</Initials>
                    <FamilyName>Wagner</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>V.</Initials>
                    <FamilyName>Rizzoli</FamilyName>
                  </BibAuthorName>
                  <Year>1995</Year>
                  <ArticleTitle Language="En">Density separation of umbilical cord blood and recovery of hemopoietic progenitor cells: implications for cord blood banking</ArticleTitle>
                  <JournalTitle>Stem Cells</JournalTitle>
                  <VolumeID>13</VolumeID>
                  <IssueID>5</IssueID>
                  <FirstPage>533</FirstPage>
                  <LastPage>540</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8528103</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/stem.5530130511</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK287gslOmsQ%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Almici, C., Carlo-Stella, C., Mangoni, L., Garau, D., Cottafavi, L., Ventura, A., Armanetti, M., Wagner, J.E., Rizzoli, V. (1995). Density separation of umbilical cord blood and recovery of hemopoietic progenitor cells: implications for cord blood banking. Stem Cells 13(5), 533–540.</BibUnstructured>
              </Citation>
              <Citation ID="CR16_9">
                <CitationNumber>16.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>K.S.</Initials>
                    <FamilyName>Tsang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K.</Initials>
                    <FamilyName>Li</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D.P.</Initials>
                    <FamilyName>Huang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.P.</Initials>
                    <FamilyName>Wong</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y.</Initials>
                    <FamilyName>Leung</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T.T.</Initials>
                    <FamilyName>Lau</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.M.</Initials>
                    <FamilyName>Chang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C.K.</Initials>
                    <FamilyName>Li</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T.F.</Initials>
                    <FamilyName>Fok</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P.M.</Initials>
                    <FamilyName>Yuen</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Dextran sedimentation in a semi-closed system for the clinical banking of umbilical cord blood</ArticleTitle>
                  <JournalTitle>Transfusion</JournalTitle>
                  <VolumeID>41</VolumeID>
                  <IssueID>3</IssueID>
                  <FirstPage>344</FirstPage>
                  <LastPage>352</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11274588</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1046/j.1537-2995.2001.41030344.x</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXivVOns7c%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Tsang, K.S., Li, K., Huang, D.P., Wong, A.P., Leung, Y., Lau, T.T., Chang, A.M., Li, C.K., Fok, T.F., Yuen, P.M. (2001). Dextran sedimentation in a semi-closed system for the clinical banking of umbilical cord blood. Transfusion 41(3), 344–352.</BibUnstructured>
              </Citation>
              <Citation ID="CR17_9">
                <CitationNumber>17.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D.T.</Initials>
                    <FamilyName>Harris</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.J.</Initials>
                    <FamilyName>Schumacher</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Rychlik</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.</Initials>
                    <FamilyName>Booth</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.</Initials>
                    <FamilyName>Acevedo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P.</Initials>
                    <FamilyName>Rubenstein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.</Initials>
                    <FamilyName>Bard</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E.A.</Initials>
                    <FamilyName>Boyse</FamilyName>
                  </BibAuthorName>
                  <Year>1994</Year>
                  <ArticleTitle Language="En">Collection, separation and cryopreservation of umbilical cord blood for use in transplantation</ArticleTitle>
                  <JournalTitle>Bone Marrow Transplant</JournalTitle>
                  <VolumeID>13</VolumeID>
                  <IssueID>2</IssueID>
                  <FirstPage>135</FirstPage>
                  <LastPage>143</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8205082</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK2c3msVKhtQ%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Harris, D.T., Schumacher, M.J., Rychlik, S., Booth, A., Acevedo, A., Rubenstein, P., Bard, J., Boyse, E.A. (1994). Collection, separation and cryopreservation of umbilical cord blood for use in transplantation. Bone Marrow Transplant. 13(2), 135–143.</BibUnstructured>
              </Citation>
              <Citation ID="CR18_9">
                <CitationNumber>18.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R.A.</Initials>
                    <FamilyName>Dracker</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">Cord blood stem cells: how to get them and what to do with them</ArticleTitle>
                  <JournalTitle>J. Hematother.</JournalTitle>
                  <VolumeID>5</VolumeID>
                  <IssueID>2</IssueID>
                  <FirstPage>145</FirstPage>
                  <LastPage>148</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8723791</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1089/scd.1.1996.5.145</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK28zgsVygtA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Dracker, R.A. (1996). Cord blood stem cells: how to get them and what to do with them. J. Hematother. 5(2), 145–148.</BibUnstructured>
              </Citation>
              <Citation ID="CR19_9">
                <CitationNumber>19.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J.A.</Initials>
                    <FamilyName>Reems</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D.</Initials>
                    <FamilyName>Fujita</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T.</Initials>
                    <FamilyName>Tyler</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R.</Initials>
                    <FamilyName>Moldwin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.D.</Initials>
                    <FamilyName>Smith</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Obtaining an accepted investigational new drug application to operate an umbilical cord blood bank</ArticleTitle>
                  <JournalTitle>Transfusion</JournalTitle>
                  <VolumeID>39</VolumeID>
                  <IssueID>4</IssueID>
                  <FirstPage>357</FirstPage>
                  <LastPage>363</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10220260</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1046/j.1537-2995.1999.39499235666.x</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK1M3jsFKltA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Reems, J.A., Fujita, D., Tyler, T., Moldwin, R., Smith, S.D. (1999). Obtaining an accepted investigational new drug application to operate an umbilical cord blood bank. Transfusion 39(4), 357–363.</BibUnstructured>
              </Citation>
              <Citation ID="CR20_9">
                <CitationNumber>20.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>T.F.</Initials>
                    <FamilyName>Zuck</FamilyName>
                  </BibAuthorName>
                  <Year>1996</Year>
                  <ArticleTitle Language="En">The applicability of cGMP to cord blood cell banking</ArticleTitle>
                  <JournalTitle>J. Hematother.</JournalTitle>
                  <VolumeID>5</VolumeID>
                  <IssueID>2</IssueID>
                  <FirstPage>135</FirstPage>
                  <LastPage>137</LastPage>
                  <Occurrence Type="PID">
                    <Handle>8723789</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1089/scd.1.1996.5.135</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK28zgsVygtg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Zuck, T.F. (1996). The applicability of cGMP to cord blood cell banking. J. Hematother. 5(2), 135–137.</BibUnstructured>
              </Citation>
              <Citation ID="CR21_9">
                <CitationNumber>21.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P.</Initials>
                    <FamilyName>Pranke</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R.R.</Initials>
                    <FamilyName>Failace</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>W.F.</Initials>
                    <FamilyName>Allebrandt</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G.</Initials>
                    <FamilyName>Steibel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F.</Initials>
                    <FamilyName>Schmidt</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N.B.</Initials>
                    <FamilyName>Nardi</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Hematologic and immunophenotypic characterization of human umbilical cord blood</ArticleTitle>
                  <JournalTitle>Acta Haematol</JournalTitle>
                  <VolumeID>105</VolumeID>
                  <FirstPage>71</FirstPage>
                  <LastPage>76</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11408707</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1159/000046537</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD3MzksV2itA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Pranke, P., Failace, R.R., Allebrandt, W.F., Steibel, G., Schmidt, F., Nardi, N.B. (2001). Hematologic and immunophenotypic characterization of human umbilical cord blood. Acta Haematol. 105, 71–76.</BibUnstructured>
              </Citation>
              <Citation ID="CR22_9">
                <CitationNumber>22.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D.</Initials>
                    <FamilyName>Harris</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Schumacher</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.</Initials>
                    <FamilyName>Locascio</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F.</Initials>
                    <FamilyName>Besencon</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G.</Initials>
                    <FamilyName>Olson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D.</Initials>
                    <FamilyName>DeLuca</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L.</Initials>
                    <FamilyName>Shenker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.</Initials>
                    <FamilyName>Bard</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E.</Initials>
                    <FamilyName>Boyse</FamilyName>
                  </BibAuthorName>
                  <Year>1992</Year>
                  <ArticleTitle Language="En">Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes</ArticleTitle>
                  <JournalTitle>Proc. Natl Acad. Sci. USA</JournalTitle>
                  <VolumeID>89</VolumeID>
                  <FirstPage>10006</FirstPage>
                  <LastPage>10010</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1438190</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.89.21.10006</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK3sXitVOnsg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Harris, D., Schumacher, M., Locascio, J., Besencon, F., Olson, G., DeLuca, D., Shenker, L., Bard, J., Boyse, E. (1992). Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes. Proc. Natl Acad. Sci. USA 89, 10006–10010.</BibUnstructured>
              </Citation>
              <Citation ID="CR23_9">
                <CitationNumber>23.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>G.</Initials>
                    <FamilyName>D’Arena</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P.</Initials>
                    <FamilyName>Musto</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N.</Initials>
                    <FamilyName>Cascavilla</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G.</Initials>
                    <FamilyName>Di Giorgio</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Fusili</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F.</Initials>
                    <FamilyName>Zendoli</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Carotenuto</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features</ArticleTitle>
                  <JournalTitle>Haematologica</JournalTitle>
                  <VolumeID>83</VolumeID>
                  <FirstPage>197</FirstPage>
                  <LastPage>203</LastPage>
                  <Occurrence Type="PID">
                    <Handle>9573672</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>D’Arena, G., Musto, P., Cascavilla, N., Di Giorgio, G., Fusili, S., Zendoli, F., Carotenuto, M. (1998). Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features. Haematologica 83, 197–203.</BibUnstructured>
              </Citation>
              <Citation ID="CR24_9">
                <CitationNumber>24.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>V.</Initials>
                    <FamilyName>Rocha</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.</Initials>
                    <FamilyName>Cornish</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E.L.</Initials>
                    <FamilyName>Sievers</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.</Initials>
                    <FamilyName>Filipovich</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F.</Initials>
                    <FamilyName>Locatelli</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C.</Initials>
                    <FamilyName>Peters</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Remberger</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G.</Initials>
                    <FamilyName>Michel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>W.</Initials>
                    <FamilyName>Arcese</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Dallorso</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K.</Initials>
                    <FamilyName>Tiedemann</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.</Initials>
                    <FamilyName>Busca</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K.W.</Initials>
                    <FamilyName>Chan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Kato</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.</Initials>
                    <FamilyName>Ortega</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Vowels</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.</Initials>
                    <FamilyName>Zander</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G.</Initials>
                    <FamilyName>Souillet</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.</Initials>
                    <FamilyName>Oakill</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.</Initials>
                    <FamilyName>Woolfrey</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.L.</Initials>
                    <FamilyName>Pay</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.</Initials>
                    <FamilyName>Green</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F.</Initials>
                    <FamilyName>Garnier</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I.</Initials>
                    <FamilyName>Ionescu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P.</Initials>
                    <FamilyName>Wernet</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G.</Initials>
                    <FamilyName>Sirchia</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P.</Initials>
                    <FamilyName>Rubinstein</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Chevret</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E.</Initials>
                    <FamilyName>Gluckman</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia</ArticleTitle>
                  <JournalTitle>Blood</JournalTitle>
                  <VolumeID>97</VolumeID>
                  <FirstPage>2962</FirstPage>
                  <LastPage>2971</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11342418</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1182/blood.V97.10.2962</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXjsl2rtLg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Rocha, V., Cornish, J., Sievers, E.L., Filipovich, A., Locatelli, F., Peters, C., Remberger, M., Michel, G., Arcese, W., Dallorso, S., Tiedemann, K., Busca, A., Chan, K.W., Kato, S., Ortega, J., Vowels, M., Zander, A., Souillet, G., Oakill, A., Woolfrey, A., Pay, A.L., Green, A., Garnier, F., Ionescu, I., Wernet, P., Sirchia, G., Rubinstein, P., Chevret, S., Gluckman, E. (2001). Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia. Blood 97, 2962–2971.</BibUnstructured>
              </Citation>
              <Citation ID="CR25_9">
                <CitationNumber>25.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Tamaki</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K.</Initials>
                    <FamilyName>Eckert</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D.</Initials>
                    <FamilyName>He</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R.</Initials>
                    <FamilyName>Sutton</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Doshe</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G.</Initials>
                    <FamilyName>Jain</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R.</Initials>
                    <FamilyName>Tushinski</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Reitsma</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B.</Initials>
                    <FamilyName>Harris</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Tsukamoto</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F.</Initials>
                    <FamilyName>Gage</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I.</Initials>
                    <FamilyName>Weissman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N.</Initials>
                    <FamilyName>Uchida</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Engraftment of sorted/expanded human central nervous system stem cells from fetal brain</ArticleTitle>
                  <JournalTitle>J. Neurosci. Res</JournalTitle>
                  <VolumeID>69</VolumeID>
                  <FirstPage>976</FirstPage>
                  <LastPage>986</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12205691</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/jnr.10412</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD38XntFGnu74%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Tamaki, S., Eckert, K., He, D., Sutton, R., Doshe, M., Jain, G., Tushinski, R., Reitsma, M., Harris, B., Tsukamoto, M., Gage, F., Weissman, I., Uchida, N. (2002). Engraftment of sorted/expanded human central nervous system stem cells from fetal brain. J. Neurosci. Res. 69, 976–986.</BibUnstructured>
              </Citation>
              <Citation ID="CR26_9">
                <CitationNumber>26.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J.G.</Initials>
                    <FamilyName>Bender</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K.L.</Initials>
                    <FamilyName>Unverzagt</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D.E.</Initials>
                    <FamilyName>Walker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>W.</Initials>
                    <FamilyName>Lee</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D.E.</Initials>
                    <FamilyName>Van Epps</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D.H.</Initials>
                    <FamilyName>Smith</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C.C.</Initials>
                    <FamilyName>Stewart</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L.B.</Initials>
                    <FamilyName>To</FamilyName>
                  </BibAuthorName>
                  <Year>1991</Year>
                  <ArticleTitle Language="En">Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry</ArticleTitle>
                  <JournalTitle>Blood</JournalTitle>
                  <VolumeID>77</VolumeID>
                  <IssueID>12</IssueID>
                  <FirstPage>2591</FirstPage>
                  <LastPage>2596</LastPage>
                  <Occurrence Type="PID">
                    <Handle>1710512</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK3M3lsFKktw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bender, J.G., Unverzagt, K.L., Walker, D.E., Lee, W., Van Epps, D.E., Smith, D.H., Stewart, C.C., To, L.B. (1991). Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometry. Blood 77(12), 2591–2596.</BibUnstructured>
              </Citation>
              <Citation ID="CR27_9">
                <CitationNumber>27.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>L.</Initials>
                    <FamilyName>Bużańska</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E.K.</Initials>
                    <FamilyName>Machaj</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B.</Initials>
                    <FamilyName>Zablocka</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Z.</Initials>
                    <FamilyName>Podja</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K.</Initials>
                    <FamilyName>Domańska-Janik</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Human cord blood-derived cells attain neuronal and glial features in vitro</ArticleTitle>
                  <JournalTitle>J. Cell Sci</JournalTitle>
                  <VolumeID>115</VolumeID>
                  <FirstPage>2131</FirstPage>
                  <LastPage>2138</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11973354</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Bużańska, L., Machaj, E.K., Zablocka, B., Podja, Z., Domańska-Janik, K. (2002). Human cord blood-derived cells attain neuronal and glial features in vitro. J. Cell Sci. 115, 2131–2138.</BibUnstructured>
              </Citation>
              <Citation ID="CR28_9">
                <CitationNumber>28.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>N.</Initials>
                    <FamilyName>Chen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.E.</Initials>
                    <FamilyName>Hudson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P.</Initials>
                    <FamilyName>Walczak</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I.</Initials>
                    <FamilyName>Misiuta</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Garbuzova-Davis</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L.</Initials>
                    <FamilyName>Jiang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.</Initials>
                    <FamilyName>Sanchez-Ramos</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P.R.</Initials>
                    <FamilyName>Sanberg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T.</Initials>
                    <FamilyName>Zigova</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.E.</Initials>
                    <FamilyName>Willing</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Human umbilical cord blood progenitors: the potential of these hematopoietic cells to become neural</ArticleTitle>
                  <JournalTitle>Stem Cells</JournalTitle>
                  <VolumeID>23</VolumeID>
                  <IssueID>10</IssueID>
                  <FirstPage>1560</FirstPage>
                  <LastPage>1570</LastPage>
                  <Occurrence Type="PID">
                    <Handle>16081669</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1634/stemcells.2004-0284</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD28XmvA%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Chen, N., Hudson, J.E., Walczak, P., Misiuta, I., Garbuzova-Davis, S., Jiang, L., Sanchez-Ramos, J., Sanberg, P.R., Zigova, T., Willing, A.E. (2005). Human umbilical cord blood progenitors: the potential of these hematopoietic cells to become neural. Stem Cells 23(10), 1560–1570.</BibUnstructured>
              </Citation>
              <Citation ID="CR29_9">
                <CitationNumber>29.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Jurga</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I.</Initials>
                    <FamilyName>Markiewicz</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.</Initials>
                    <FamilyName>Sarnowska</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.</Initials>
                    <FamilyName>Habich</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H.</Initials>
                    <FamilyName>Kozlowska</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B.</Initials>
                    <FamilyName>Lukomska</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L.</Initials>
                    <FamilyName>Bużańska</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K.</Initials>
                    <FamilyName>Domańska-Janik</FamilyName>
                  </BibAuthorName>
                  <Year>2006</Year>
                  <ArticleTitle Language="En">Neurogenic potential of human umbilical cord blood: neural-like stem cells depend on previous long-term culture conditions</ArticleTitle>
                  <JournalTitle>J. Neurosci. Res</JournalTitle>
                  <VolumeID>83</VolumeID>
                  <FirstPage>627</FirstPage>
                  <LastPage>637</LastPage>
                  <Occurrence Type="PID">
                    <Handle>16435396</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/jnr.20766</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD28Xislyisbo%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Jurga, M., Markiewicz, I., Sarnowska, A., Habich, A., Kozlowska, H., Lukomska, B., Bużańska, L., Domańska-Janik, K. (2006). Neurogenic potential of human umbilical cord blood: neural-like stem cells depend on previous long-term culture conditions. J. Neurosci. Res. 83, 627–637.</BibUnstructured>
              </Citation>
              <Citation ID="CR30_9">
                <CitationNumber>30.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J.R.</Initials>
                    <FamilyName>Sanchez-Ramos</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Song</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.G.</Initials>
                    <FamilyName>Kamath</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T.</Initials>
                    <FamilyName>Zigova</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.</Initials>
                    <FamilyName>Willing</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F.</Initials>
                    <FamilyName>Cardozo-Pelaez</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T.</Initials>
                    <FamilyName>Stedeford</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Chopp</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P.R.</Initials>
                    <FamilyName>Sanberg</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Expression of neural markers in human umbilical cord blood</ArticleTitle>
                  <JournalTitle>Exp. Neurol</JournalTitle>
                  <VolumeID>171</VolumeID>
                  <FirstPage>109</FirstPage>
                  <LastPage>115</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11520125</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1006/exnr.2001.7748</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXmtFyqt70%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sanchez-Ramos, J.R., Song, S., Kamath, S.G., Zigova, T., Willing, A., Cardozo-Pelaez, F., Stedeford, T., Chopp, M., Sanberg, P.R. (2001). Expression of neural markers in human umbilical cord blood. Exp. Neurol. 171, 109–115.</BibUnstructured>
              </Citation>
              <Citation ID="CR31_9">
                <CitationNumber>31.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A.G.</Initials>
                    <FamilyName>Wu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Michejda</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.</Initials>
                    <FamilyName>Mazumder</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K.R.</Initials>
                    <FamilyName>Meehan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F.A.</Initials>
                    <FamilyName>Menendez</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.G.</Initials>
                    <FamilyName>Tchabo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R.</Initials>
                    <FamilyName> Slack</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.P.</Initials>
                    <FamilyName>Johnson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.A.</Initials>
                    <FamilyName>Bellanti</FamilyName>
                  </BibAuthorName>
                  <Year>1999</Year>
                  <ArticleTitle Language="En">Analysis and characterization of hematopoietic progenitor cells from fetal bone marrow adult bone marrow peripheral blood, and cord blood</ArticleTitle>
                  <JournalTitle>Pediatr. Res.</JournalTitle>
                  <VolumeID>46</VolumeID>
                  <IssueID>2</IssueID>
                  <FirstPage>163</FirstPage>
                  <LastPage>169</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10447109</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1203/00006450-199908000-00006</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DyaK1MznsVOktw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Wu, A.G., Michejda, M., Mazumder, A., Meehan, K.R., Menendez, F.A., Tchabo, J.G., Slack, R., Johnson, M.P., Bellanti, J.A. (1999). Analysis and characterization of hematopoietic progenitor cells from fetal bone marrow adult bone marrow peripheral blood, and cord blood. Pediatr. Res. 46(2), 163–169.</BibUnstructured>
              </Citation>
              <Citation ID="CR32_9">
                <CitationNumber>32.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>T.</Initials>
                    <FamilyName>Zigova</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Song</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.E.</Initials>
                    <FamilyName>Willing</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.E.</Initials>
                    <FamilyName>Hudson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.B.</Initials>
                    <FamilyName>Newman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Saporta</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.</Initials>
                    <FamilyName>Sanchez-Ramos</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P.R.</Initials>
                    <FamilyName>Sanberg</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Human umbilical cord blood cells express neural antigens after transplantation into the developing rat brain</ArticleTitle>
                  <JournalTitle>Cell Transplant</JournalTitle>
                  <VolumeID>11</VolumeID>
                  <IssueID>3</IssueID>
                  <FirstPage>265</FirstPage>
                  <LastPage>274</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12075992</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Zigova, T., Song, S., Willing, A.E., Hudson, J.E., Newman, M.B., Saporta, S., Sanchez-Ramos, J., Sanberg, P.R. (2002). Human umbilical cord blood cells express neural antigens after transplantation into the developing rat brain. Cell Transplant. 11(3), 265–274.</BibUnstructured>
              </Citation>
              <Citation ID="CR33_9">
                <CitationNumber>33.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A.A.</Initials>
                    <FamilyName>Cardosa</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.L.</Initials>
                    <FamilyName>Li</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P.</Initials>
                    <FamilyName>Batard</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.</Initials>
                    <FamilyName>Hatzfeld</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E.L.</Initials>
                    <FamilyName>Brown</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.P.</Initials>
                    <FamilyName>Levesque</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H.</Initials>
                    <FamilyName>Sookdeo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B.</Initials>
                    <FamilyName>Panterne</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P.</Initials>
                    <FamilyName>Sansilvestri</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.C.</Initials>
                    <FamilyName>Clark</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.</Initials>
                    <FamilyName>Hatzfeld</FamilyName>
                  </BibAuthorName>
                  <Year>1993</Year>
                  <ArticleTitle Language="En">Released from quiescence of CD34<Superscript> +</Superscript>CD38<Superscript>−</Superscript>human umbilical cord blood cells reveal their potentiality to engraft adults</ArticleTitle>
                  <JournalTitle>Proc. Natl Acad. Sci. USA</JournalTitle>
                  <VolumeID>90</VolumeID>
                  <FirstPage>8707</FirstPage>
                  <LastPage>8711</LastPage>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.90.18.8707</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Cardosa, A.A., Li, M.L., Batard, P., Hatzfeld, A., Brown, E.L., Levesque, J.P., Sookdeo, H., Panterne, B., Sansilvestri, P., Clark, S.C., Hatzfeld, J. (1993). Released from quiescence of CD34+CD38− human umbilical cord blood cells reveal their potentiality to engraft adults. Proc. Natl Acad. Sci. USA 90, 8707–8711.</BibUnstructured>
              </Citation>
              <Citation ID="CR34_9">
                <CitationNumber>34.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>P.</Initials>
                    <FamilyName>Conrad</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.G.</Initials>
                    <FamilyName>Emerson</FamilyName>
                  </BibAuthorName>
                  <Year>1998</Year>
                  <ArticleTitle Language="En">Ex vivo expansion of hematopoietic cells from umbilical cord blood for clinical transplantation</ArticleTitle>
                  <JournalTitle>J. Leuk. Biol</JournalTitle>
                  <VolumeID>64</VolumeID>
                  <FirstPage>147</FirstPage>
                  <LastPage>155</LastPage>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DyaK1cXltFymurY%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Conrad, P., Emerson, S.G. (1998). Ex vivo expansion of hematopoietic cells from umbilical cord blood for clinical transplantation. J. Leuk. Biol. 64, 147–155.</BibUnstructured>
              </Citation>
              <Citation ID="CR35_9">
                <CitationNumber>35.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>N.</Initials>
                    <FamilyName>Uchida</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D.W.</Initials>
                    <FamilyName>Buck</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D.</Initials>
                    <FamilyName>He</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.J.</Initials>
                    <FamilyName>Reitsma</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Masek</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T.V.</Initials>
                    <FamilyName>Phan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.S.</Initials>
                    <FamilyName>Tsukamoto</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>F.H.</Initials>
                    <FamilyName>Gage</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>I.L.</Initials>
                    <FamilyName>Weissman</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">Direct isolation of human central nervous system stem cells</ArticleTitle>
                  <JournalTitle>Proc. Natl. Acad. Sci. USA</JournalTitle>
                  <VolumeID>97</VolumeID>
                  <FirstPage>14720</FirstPage>
                  <LastPage>14725</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11121071</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1073/pnas.97.26.14720</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3MXitVGgtg%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Uchida, N., Buck, D.W., He, D., Reitsma, M.J., Masek, M., Phan, T.V., Tsukamoto, A.S., Gage, F.H., Weissman, I.L. (2000). Direct isolation of human central nervous system stem cells. Proc. Natl. Acad. Sci. USA 97, 14720–14725.</BibUnstructured>
              </Citation>
              <Citation ID="CR36_9">
                <CitationNumber>36.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>H.S.</Initials>
                    <FamilyName>Goodwin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.R.</Initials>
                    <FamilyName>Bicknese</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.N.</Initials>
                    <FamilyName>Chien</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>B.D.</Initials>
                    <FamilyName>Bogucki</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C.O.</Initials>
                    <FamilyName>Quinn</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D.A.</Initials>
                    <FamilyName>Wall</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Multilineage differentiation activity by cells isolated from umbilical cord blood: expression of bone, fat, and neural markers</ArticleTitle>
                  <JournalTitle>Biol. Blood Marrow Transplant.</JournalTitle>
                  <VolumeID>7</VolumeID>
                  <FirstPage>581</FirstPage>
                  <LastPage>588</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11760145</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1053/bbmt.2001.v7.pm11760145</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD38%2FjsVylsw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Goodwin, H.S., Bicknese, A.R., Chien, S.N., Bogucki, B.D., Quinn, C.O., Wall, D.A. (2001). Multilineage differentiation activity by cells isolated from umbilical cord blood: expression of bone, fat, and neural markers. Biol. Blood Marrow Transplant. 7: 581–588.</BibUnstructured>
              </Citation>
              <Citation ID="CR37_9">
                <CitationNumber>37.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S.-E.</Initials>
                    <FamilyName>Yang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C.-W.</Initials>
                    <FamilyName>Ha</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.H.</Initials>
                    <FamilyName>Jung</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H.-J.</Initials>
                    <FamilyName>Jin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.K.</Initials>
                    <FamilyName>Lee</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H.S.</Initials>
                    <FamilyName>Song</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.J.</Initials>
                    <FamilyName>Choi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>W.</Initials>
                    <FamilyName>Oh</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y.-S.</Initials>
                    <FamilyName>Yang</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Mesenchymal stem/progenitor cells developed in cultures from UC blood</ArticleTitle>
                  <JournalTitle>Cytotherapy</JournalTitle>
                  <VolumeID>6</VolumeID>
                  <FirstPage>476</FirstPage>
                  <LastPage>486</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15512914</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1080/14653240410005041</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Yang, S.-E., Ha, C.-W., Jung, M.H., Jin, H.-J., Lee, M.K., Song, H.S., Choi, S.J., Oh, W., Yang, Y.-S. (2004). Mesenchymal stem/progenitor cells developed in cultures from UC blood. Cytotherapy 6, 476–486.</BibUnstructured>
              </Citation>
              <Citation ID="CR38_9">
                <CitationNumber>38.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>E.H.</Initials>
                    <FamilyName>Javazon</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K.J.</Initials>
                    <FamilyName>Beggs</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.W.</Initials>
                    <FamilyName>Flake</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Mesenchymal stem cells: paradoxes of passaging</ArticleTitle>
                  <JournalTitle>Exp. Hematol</JournalTitle>
                  <VolumeID>32</VolumeID>
                  <FirstPage>414</FirstPage>
                  <LastPage>425</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15145209</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1016/j.exphem.2004.02.004</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2cXktVCqtrg%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Javazon, E.H., Beggs, K.J., Flake, A.W. (2004). Mesenchymal stem cells: paradoxes of passaging. Exp. Hematol. 32, 414–425.</BibUnstructured>
              </Citation>
              <Citation ID="CR39_9">
                <CitationNumber>39.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>G.</Initials>
                    <FamilyName>Kögler</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Sensken</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.A.</Initials>
                    <FamilyName>Airey</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T.</Initials>
                    <FamilyName>Trapp</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Müschen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N.</Initials>
                    <FamilyName>Feldhahn</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Liedtke</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R.V.</Initials>
                    <FamilyName>Sorg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.</Initials>
                    <FamilyName>Fischer</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C.</Initials>
                    <FamilyName>Rosenbaum</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Greschat</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.</Initials>
                    <FamilyName>Knipper</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.</Initials>
                    <FamilyName>Bender</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Ö.</Initials>
                    <FamilyName>Degistirici</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.</Initials>
                    <FamilyName>Gao</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.I.</Initials>
                    <FamilyName>Caplan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E.J.</Initials>
                    <FamilyName>Colletti</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>G.</Initials>
                    <FamilyName>Almeida-Porada</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H.W.</Initials>
                    <FamilyName>Müller</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E.</Initials>
                    <FamilyName>Zanjani</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P.</Initials>
                    <FamilyName>Wernet</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential</ArticleTitle>
                  <JournalTitle>J. Exp. Med</JournalTitle>
                  <VolumeID>200</VolumeID>
                  <FirstPage>123</FirstPage>
                  <LastPage>135</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15263023</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1084/jem.20040440</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Kögler, G., Sensken, S., Airey, J.A., Trapp, T., Müschen, M., Feldhahn, N., Liedtke, S., Sorg, R.V., Fischer, J., Rosenbaum, C., Greschat, S., Knipper, A., Bender, J., Degistirici, Ö., Gao, J., Caplan, A.I., Colletti, E.J., Almeida-Porada, G., Müller, H.W., Zanjani, E., Wernet, P. (2004). A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J. Exp. Med. 200, 123–135.</BibUnstructured>
              </Citation>
              <Citation ID="CR40_9">
                <CitationNumber>40.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Robinson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T.</Initials>
                    <FamilyName>Niu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>de Lima</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.</Initials>
                    <FamilyName>Ng</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H.</Initials>
                    <FamilyName>Yang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.</Initials>
                    <FamilyName>McMannis</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Karandish</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T.</Initials>
                    <FamilyName>Sadeghi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P.</Initials>
                    <FamilyName>Fu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>de Angel</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>O’Connor</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R.</Initials>
                    <FamilyName>Champlin</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E.</Initials>
                    <FamilyName>Shpall</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Ex vivo expansion of umbilical cord blood</ArticleTitle>
                  <JournalTitle>Cytotherapy</JournalTitle>
                  <VolumeID>7</VolumeID>
                  <FirstPage>243</FirstPage>
                  <LastPage>250</LastPage>
                  <Occurrence Type="PID">
                    <Handle>16081350</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1080/14653240510027172</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXpsVaitrk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Robinson, S., Niu, T., de Lima, M., Ng, J., Yang, H., McMannis, J., Karandish, S., Sadeghi, T., Fu, P., de Angel, M., O’Connor, S., Champlin, R., Shpall, E. (2005). Ex vivo expansion of umbilical cord blood. Cytotherapy 7, 243–250.</BibUnstructured>
              </Citation>
              <Citation ID="CR41_9">
                <CitationNumber>41.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S.A.</Initials>
                    <FamilyName>Wexler</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C.</Initials>
                    <FamilyName>Donaldson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P.</Initials>
                    <FamilyName>Denning-Kendall</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C.</Initials>
                    <FamilyName>Rice</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.M.</Initials>
                    <FamilyName>Hows</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Adult bone marrow is a rich source of human mesenchymal ‘stem’ cells but umbilical cord blood and mobilized adult blood are not</ArticleTitle>
                  <JournalTitle>Br. J. Haematol</JournalTitle>
                  <VolumeID>121</VolumeID>
                  <FirstPage>368</FirstPage>
                  <LastPage>374</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12694261</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1046/j.1365-2141.2003.04284.x</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Wexler, S.A., Donaldson, C., Denning-Kendall, P., Rice, C., Hows, J.M. (2003). Adult bone marrow is a rich source of human mesenchymal ‘stem’ cells but umbilical cord blood and mobilized adult blood are not. Br. J. Haematol. 121, 368–374.</BibUnstructured>
              </Citation>
              <Citation ID="CR42_9">
                <CitationNumber>42.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J.</Initials>
                    <FamilyName>Chen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P.R.</Initials>
                    <FamilyName>Sanberg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y.</Initials>
                    <FamilyName>Li</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L.</Initials>
                    <FamilyName>Wang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Lu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.E.</Initials>
                    <FamilyName>Willing</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.</Initials>
                    <FamilyName>Sanchez-Ramos</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Chopp</FamilyName>
                  </BibAuthorName>
                  <Year>2001</Year>
                  <ArticleTitle Language="En">Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats</ArticleTitle>
                  <JournalTitle>Stroke</JournalTitle>
                  <VolumeID>32</VolumeID>
                  <FirstPage>2682</FirstPage>
                  <LastPage>2688</LastPage>
                  <Occurrence Type="PID">
                    <Handle>11692034</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1161/hs1101.098367</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:STN:280:DC%2BD3MnktFemsw%3D%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Chen, J., Sanberg, P.R., Li, Y., Wang, L., Lu, M., Willing, A.E., Sanchez-Ramos, J., Chopp, M. (2001). Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke 32, 2682–2688.</BibUnstructured>
              </Citation>
              <Citation ID="CR43_9">
                <CitationNumber>43.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>J.D.</Initials>
                    <FamilyName>Newcomb</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C.T.</Initials>
                    <FamilyName>Ajmo</FamilyName>
                    <Suffix>Jr</Suffix>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C.D.</Initials>
                    <FamilyName>Sanberg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P.R.</Initials>
                    <FamilyName>Sanberg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K.R.</Initials>
                    <FamilyName>Pennypacker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.E.</Initials>
                    <FamilyName>Willing</FamilyName>
                  </BibAuthorName>
                  <Year>2006</Year>
                  <ArticleTitle Language="En">Timing of cord blood treatment after experimental stroke determines therapeutic efficacy</ArticleTitle>
                  <JournalTitle>Cell Transplant.</JournalTitle>
                  <VolumeID>15</VolumeID>
                  <FirstPage>213</FirstPage>
                  <LastPage>223</LastPage>
                  <Occurrence Type="PID">
                    <Handle>16719056</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.3727/000000006783982043</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Newcomb, J.D., Ajmo, Jr. C.T., Sanberg, C.D., Sanberg, P.R., Pennypacker, K.R., Willing, A.E. (2006). Timing of cord blood treatment after experimental stroke determines therapeutic efficacy. Cell Transplant. 15, 213–223.</BibUnstructured>
              </Citation>
              <Citation ID="CR44_9">
                <CitationNumber>44.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Vendrame</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.</Initials>
                    <FamilyName>Cassady</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.</Initials>
                    <FamilyName>Newcomb</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T.</Initials>
                    <FamilyName>Butler</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K.R.</Initials>
                    <FamilyName>Pennypacker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T.</Initials>
                    <FamilyName>Zigova</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C.</Initials>
                    <FamilyName>Davis Sanberg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P.R.</Initials>
                    <FamilyName>Sanberg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.E.</Initials>
                    <FamilyName>Willing</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependency rescues behavioral deficits and reduces infarct volume</ArticleTitle>
                  <JournalTitle>Stroke</JournalTitle>
                  <VolumeID>35</VolumeID>
                  <FirstPage>2390</FirstPage>
                  <LastPage>2395</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15322304</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1161/01.STR.0000141681.06735.9b</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Vendrame, M., Cassady, J., Newcomb, J., Butler, T., Pennypacker, K.R., Zigova, T., Davis Sanberg, C., Sanberg, P.R., Willing, A.E. (2004). Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependency rescues behavioral deficits and reduces infarct volume. Stroke 35, 2390–2395.</BibUnstructured>
              </Citation>
              <Citation ID="CR45_9">
                <CitationNumber>45.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Vendrame</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C.</Initials>
                    <FamilyName>Gemma</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D.</Initials>
                    <FamilyName>de Mesquita</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L.</Initials>
                    <FamilyName>Collier</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P.C.</Initials>
                    <FamilyName>Bickford</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C.</Initials>
                    <FamilyName>Davis Sanberg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P.R.</Initials>
                    <FamilyName>Sanberg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K.R.</Initials>
                    <FamilyName>Pennypacker</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.E.</Initials>
                    <FamilyName>Willing</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Anti-inflammatory effects of human cord blood cells in a rat model of stroke</ArticleTitle>
                  <JournalTitle>Stem Cells Dev</JournalTitle>
                  <VolumeID>14</VolumeID>
                  <FirstPage>595</FirstPage>
                  <LastPage>604</LastPage>
                  <Occurrence Type="PID">
                    <Handle>16305344</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1089/scd.2005.14.595</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXht1GisLnI</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Vendrame, M., Gemma, C., de Mesquita, D., Collier, L., Bickford, P.C., Davis Sanberg, C., Sanberg, P.R., Pennypacker, K.R., Willing, A.E. (2005). Anti-inflammatory effects of human cord blood cells in a rat model of stroke. Stem Cells Dev. 14, 595–604.</BibUnstructured>
              </Citation>
              <Citation ID="CR46_9">
                <CitationNumber>46.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A.E.</Initials>
                    <FamilyName>Willing</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.</Initials>
                    <FamilyName>Lixian</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Milliken</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Poulos</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T.</Initials>
                    <FamilyName>Zigova</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Song</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C.</Initials>
                    <FamilyName>Hart</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.</Initials>
                    <FamilyName>Sanchez-Ramos</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P.R.</Initials>
                    <FamilyName>Sanberg</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Intravenous versus intrastriatal cord blood administration in a rodent model of stroke</ArticleTitle>
                  <JournalTitle>J. Neurosci. Res.</JournalTitle>
                  <VolumeID>73</VolumeID>
                  <IssueID>3</IssueID>
                  <FirstPage>296</FirstPage>
                  <LastPage>307</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12868063</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1002/jnr.10659</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXmt1Gjsrw%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Willing, A.E., Lixian, J., Milliken, M., Poulos, S., Zigova, T., Song, S., Hart, C., Sanchez-Ramos, J., Sanberg, P.R. (2003). Intravenous versus intrastriatal cord blood administration in a rodent model of stroke. J. Neurosci. Res. 73(3), 296–307.</BibUnstructured>
              </Citation>
              <Citation ID="CR47_9">
                <CitationNumber>47.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>A.E.</Initials>
                    <FamilyName>Willing</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Vendrame</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.</Initials>
                    <FamilyName>Mallery</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C.J.</Initials>
                    <FamilyName>Cassady</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C.D.</Initials>
                    <FamilyName>Davis</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.</Initials>
                    <FamilyName>Sanchez-Ramos</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P.R.</Initials>
                    <FamilyName>Sanberg</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Mobilized peripheral blood cells administered intravenously produce functional recovery in stroke</ArticleTitle>
                  <JournalTitle>Cell Transplant.</JournalTitle>
                  <VolumeID>12</VolumeID>
                  <FirstPage>449</FirstPage>
                  <LastPage>454</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12911133</Handle>
                  </Occurrence>
<Occurrence Type="DOI">
<Handle>10.3727/000000003108746885</Handle>
</Occurrence>
                </BibArticle>
                <BibUnstructured>Willing, A.E., Vendrame, M., Mallery, J., Cassady, C.J., Davis, C.D., Sanchez-Ramos, J., Sanberg, P.R. (2003) Mobilized peripheral blood cells administered intravenously produce functional recovery in stroke. Cell Transplant. 12, 449–454.</BibUnstructured>
              </Citation>
              <Citation ID="CR48_9">
                <CitationNumber>48.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R.</Initials>
                    <FamilyName>Chen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N.</Initials>
                    <FamilyName>Ende</FamilyName>
                  </BibAuthorName>
                  <Year>2000</Year>
                  <ArticleTitle Language="En">The potential for the use of mononuclear cells from human umbilical cord blood in the treatment of amyotrophic lateral sclerosis in SOD1 mice</ArticleTitle>
                  <JournalTitle>J. Med</JournalTitle>
                  <VolumeID>31</VolumeID>
                  <FirstPage>21</FirstPage>
                  <LastPage>30</LastPage>
                  <Occurrence Type="PID">
                    <Handle>10998753</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3cXjtFaqurk%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Chen, R., Ende, N. (2000). The potential for the use of mononuclear cells from human umbilical cord blood in the treatment of amyotrophic lateral sclerosis in SOD1 mice. J. Med. 31, 21–30.</BibUnstructured>
              </Citation>
              <Citation ID="CR49_9">
                <CitationNumber>49.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Garbuzova-Davis</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.E.</Initials>
                    <FamilyName>Willing</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T.</Initials>
                    <FamilyName>Zigova</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Saporta</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E.B.</Initials>
                    <FamilyName>Justen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.C.</Initials>
                    <FamilyName>Lane</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.E.</Initials>
                    <FamilyName>Hudson</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N.</Initials>
                    <FamilyName>Chen</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C.D.</Initials>
                    <FamilyName>Davis</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P.R.</Initials>
                    <FamilyName>Sanberg</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: distribution, migration and differentiation</ArticleTitle>
                  <JournalTitle>J. Hematother. Stem Cell Res</JournalTitle>
                  <VolumeID>12</VolumeID>
                  <FirstPage>255</FirstPage>
                  <LastPage>270</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12857367</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1089/152581603322022990</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXkvVSmu7o%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Garbuzova-Davis, S., Willing, A.E., Zigova, T., Saporta, S., Justen, E.B., Lane, J.C., Hudson, J.E., Chen, N., Davis, C.D., Sanberg, P.R. (2003). Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: distribution, migration and differentiation. J. Hematother. Stem Cell Res. 12, 255–270.</BibUnstructured>
              </Citation>
              <Citation ID="CR50_9">
                <CitationNumber>50.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Garbuzova-Davis</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.E.</Initials>
                    <FamilyName>Willing</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T.</Initials>
                    <FamilyName>Desjarlais</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C.</Initials>
                    <FamilyName>Davis Sanberg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P.R.</Initials>
                    <FamilyName>Sanberg</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Transplantation of human umbilical cord blood cells benefits an animal model of Sanfilippo syndrome type B</ArticleTitle>
                  <JournalTitle>Stem Cells Dev.</JournalTitle>
                  <VolumeID>14</VolumeID>
                  <FirstPage>384</FirstPage>
                  <LastPage>394</LastPage>
                  <Occurrence Type="PID">
                    <Handle>16137227</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1089/scd.2005.14.384</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXpslaisLs%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Garbuzova-Davis, S., Willing, A.E., Desjarlais, T., Davis Sanberg, C., Sanberg, P.R. (2005).Transplantation of human umbilical cord blood cells benefits an animal model of Sanfilippo syndrome type B. Stem Cells Dev. 14, 384–394.</BibUnstructured>
              </Citation>
              <Citation ID="CR51_9">
                <CitationNumber>51.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Garbuzova-Davis</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.J.</Initials>
                    <FamilyName>Gografe</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C.</Initials>
                    <FamilyName>Davis Sanberg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.E.</Initials>
                    <FamilyName>Willing</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Saporta</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>D.F.</Initials>
                    <FamilyName>Cameron</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>T.</Initials>
                    <FamilyName>Desjarlais</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.</Initials>
                    <FamilyName>Daily</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>N.</Initials>
                    <FamilyName>Kuzmin-Nichols</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>W.</Initials>
                    <FamilyName>Chamizo</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>S.K.</Initials>
                    <FamilyName>Klasko</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P.R.</Initials>
                    <FamilyName>Sanberg</FamilyName>
                  </BibAuthorName>
                  <Year>2006</Year>
                  <ArticleTitle Language="En">Maternal transplantation of human umbilical cord blood cells provides prenatal therapy in Sanfilipo type B mouse model</ArticleTitle>
                  <JournalTitle>FASEB J</JournalTitle>
                  <VolumeID>20</VolumeID>
                  <FirstPage>485</FirstPage>
                  <LastPage>487</LastPage>
                  <Occurrence Type="PID">
                    <Handle>16401642</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD28Xis1Ojtr0%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Garbuzova-Davis, S., Gografe, S.J., Davis Sanberg, C., Willing, A.E., Saporta, S., Cameron, D.F., Desjarlais, T., Daily, J., Kuzmin-Nichols, N., Chamizo, W., Klasko, S.K., Sanberg, P.R. (2006). Maternal transplantation of human umbilical cord blood cells provides prenatal therapy in Sanfilipo type B mouse model. FASEB J. 20, 485–487.</BibUnstructured>
              </Citation>
              <Citation ID="CR52_9">
                <CitationNumber>52.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>R.J.</Initials>
                    <FamilyName>Henning</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>H.</Initials>
                    <FamilyName>Abu-Ali</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.U.</Initials>
                    <FamilyName>Balis</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.B.</Initials>
                    <FamilyName>Morgan</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.E.</Initials>
                    <FamilyName>Willing</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P.R.</Initials>
                    <FamilyName>Sanberg</FamilyName>
                  </BibAuthorName>
                  <Year>2004</Year>
                  <ArticleTitle Language="En">Human umbilical cord blood mononuclear cells for the treatment of acute myocardial infarction</ArticleTitle>
                  <JournalTitle>Cell Transplant.</JournalTitle>
                  <VolumeID>13</VolumeID>
                  <FirstPage>729</FirstPage>
                  <LastPage>739</LastPage>
                  <Occurrence Type="PID">
                    <Handle>15690974</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.3727/000000004783983477</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Henning, R.J., Abu-Ali, H., Balis, J.U., Morgan, M.B., Willing, A.E., Sanberg, P.R. (2004).Human umbilical cord blood mononuclear cells for the treatment of acute myocardial infarction. Cell Transplant. 13, 729–739.</BibUnstructured>
              </Citation>
              <Citation ID="CR53_9">
                <CitationNumber>53.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>D.</Initials>
                    <FamilyName>Lu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P.R.</Initials>
                    <FamilyName>Sanberg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.</Initials>
                    <FamilyName>Mahmood</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>Y.</Initials>
                    <FamilyName>Li</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L.</Initials>
                    <FamilyName>Wang</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.</Initials>
                    <FamilyName>Sanchez-Ramos</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.</Initials>
                    <FamilyName>Chopp</FamilyName>
                  </BibAuthorName>
                  <Year>2002</Year>
                  <ArticleTitle Language="En">Intravenous administration of human umbilical cord blood reduces neurological deficit in the rat after traumatic brain injury</ArticleTitle>
                  <JournalTitle>Cell Transplant</JournalTitle>
                  <VolumeID>11</VolumeID>
                  <FirstPage>275</FirstPage>
                  <LastPage>281</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12075993</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Lu, D., Sanberg, P.R., Mahmood, A., Li, Y., Wang, L., Sanchez-Ramos, J., Chopp, M. (2002). Intravenous administration of human umbilical cord blood reduces neurological deficit in the rat after traumatic brain injury. Cell Transplant. 11, 275–281.</BibUnstructured>
              </Citation>
              <Citation ID="CR54_9">
                <CitationNumber>54.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>S.</Initials>
                    <FamilyName>Saporta</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.-J.</Initials>
                    <FamilyName>Kim</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.E.</Initials>
                    <FamilyName>Willing</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>E.S.</Initials>
                    <FamilyName>Fu</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C.D.</Initials>
                    <FamilyName>Davis</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P.R.</Initials>
                    <FamilyName>Sanberg</FamilyName>
                  </BibAuthorName>
                  <Year>2003</Year>
                  <ArticleTitle Language="En">Human umbilical cord blood stem cells infusion in spinal cord injury: engraftment and beneficial influence on behavior</ArticleTitle>
                  <JournalTitle>J. Hematother. Stem Cell Res</JournalTitle>
                  <VolumeID>12</VolumeID>
                  <FirstPage>271</FirstPage>
                  <LastPage>278</LastPage>
                  <Occurrence Type="PID">
                    <Handle>12857368</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1089/152581603322023007</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD3sXkvVSmu7s%3D</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Saporta, S., Kim, J.-J., Willing, A.E., Fu, E.S., Davis, C.D., Sanberg, P.R. (2003). Human umbilical cord blood stem cells infusion in spinal cord injury: engraftment and beneficial influence on behavior. J. Hematother. Stem Cell Res. 12, 271–278.</BibUnstructured>
              </Citation>
              <Citation ID="CR55_9">
                <CitationNumber>55.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>W.</Initials>
                    <FamilyName>Sun</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>L.</Initials>
                    <FamilyName>Buzanska</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>K.</Initials>
                    <FamilyName>Domanska-Janik</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>R.J.</Initials>
                    <FamilyName>Salvi</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>M.K.</Initials>
                    <FamilyName>Stachowiakc</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Voltage-sensitive and ligand-gated channels in differentiating neural stem-like cells derived from the nonhematopoietic fraction of human umbilical cord blood</ArticleTitle>
                  <JournalTitle>Stem Cells</JournalTitle>
                  <VolumeID>23</VolumeID>
                  <FirstPage>931</FirstPage>
                  <LastPage>945</LastPage>
                  <Occurrence Type="PID">
                    <Handle>16043459</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1634/stemcells.2004-0316</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXhtVemsrbI</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Sun, W., Buzanska, L., Domanska-Janik, K., Salvi, R.J., Stachowiakc, M.K. (2005). Voltage-sensitive and ligand-gated channels in differentiating neural stem-like cells derived from the nonhematopoietic fraction of human umbilical cord blood. Stem Cells 23, 931–945.</BibUnstructured>
              </Citation>
              <Citation ID="CR56_9">
                <CitationNumber>56.</CitationNumber>
                <BibArticle>
                  <BibAuthorName>
                    <Initials>M.B.</Initials>
                    <FamilyName>Newman</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>A.E.</Initials>
                    <FamilyName>Willing</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>J.J.</Initials>
                    <FamilyName>Mansrea</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>C.</Initials>
                    <FamilyName>Davis-Sanberg</FamilyName>
                  </BibAuthorName>
                  <BibAuthorName>
                    <Initials>P.R.</Initials>
                    <FamilyName>Sanberg</FamilyName>
                  </BibAuthorName>
                  <Year>2005</Year>
                  <ArticleTitle Language="En">Stroke-induced migration of human umbilical cord blood cells: time course and cytokines</ArticleTitle>
                  <JournalTitle>Stem Cells Dev.</JournalTitle>
                  <VolumeID>14</VolumeID>
                  <IssueID>5</IssueID>
                  <FirstPage>576</FirstPage>
                  <LastPage>586</LastPage>
                  <Occurrence Type="PID">
                    <Handle>16305342</Handle>
                  </Occurrence>
                  <Occurrence Type="DOI">
                    <Handle>10.1089/scd.2005.14.576</Handle>
                  </Occurrence>
                  <Occurrence Type="COI">
                    <Handle>1:CAS:528:DC%2BD2MXht1GisLnO</Handle>
                  </Occurrence>
                </BibArticle>
                <BibUnstructured>Newman, M.B., Willing, A.E., Mansrea, J.J., Davis-Sanberg, C., Sanberg, P.R. (2005). Stroke-induced migration of human umbilical cord blood cells: time course and cytokines. Stem Cells Dev. 14(5), 576–586.</BibUnstructured>
              </Citation>
            </Bibliography>
          </ChapterBackmatter>
        </Chapter>
      </Part>
    </Book>
  </Series>
</Publisher>